question,answer,contexts,contexts_ids,ground_truth,goldPassages
What is the implication of histone lysine methylation in medulloblastoma?,"Yes, histone lysine methylation has implications in medulloblastoma. Specifically, H3K27 methylation appears to play a role in Group 3 and Group 4 medulloblastomas, as","Context: Recent studies showed frequent mutations in histone H3 lysine 27 (H3K27)  demethylases in medulloblastomas of Group 3 and Group 4, suggesting a role for  H3K27 methylation in these tumors. Indeed, trimethylated H3K27 (H3K27me3) levels, Context: Copy number aberrations of genes with critical roles in writing, reading,  removing and blocking the state of histone lysine methylation, particularly at  H3K9, suggest that defective control of the histone code contributes to the, Context: Recent studies showed frequent mutations in histone H3 lysine 27 (H3K27)  demethylases in medulloblastomas of Group 3 and Group 4, suggesting a role for  H3K27 methylation in these tumors. Indeed, trimethylated H3K27 (H3K27me3) levels, Context: Recent studies showed frequent mutations in histone H3 lysine 27 (H3K27)  demethylases in medulloblastomas of Group 3 and Group 4, suggesting a role for  H3K27 methylation in these tumors. Indeed, trimethylated H3K27 (H3K27me3) levels, Context: Recent studies showed frequent mutations in histone H3 lysine 27 (H3K27)  demethylases in medulloblastomas of Group 3 and Group 4, suggesting a role for  H3K27 methylation in these tumors. Indeed, trimethylated H3K27 (H3K27me3) levels, Context: Recent studies showed frequent mutations in histone H3 lysine 27 (H3K27)  demethylases in medulloblastomas of Group 3 and Group 4, suggesting a role for  H3K27 methylation in these tumors. Indeed, trimethylated H3K27 (H3K27me3) levels","23179372, 19270706, 23179372, 23179372, 23179372, 23179372","Aberrant patterns of H3K4, H3K9, and H3K27 histone lysine methylation were shown to result in histone code alterations, which induce changes in gene expression, and affect the proliferation rate of cells in medulloblastoma.","23179372, 19270706, 23184418"
Which human gene encode for DNA polymerase θ?,"Yes, the POLQ gene encodes for DNA polymerase θ in humans. This is explicitly stated in the context information provided.","Context: DNA polymerase theta (pol θ) is encoded in the genomes of many eukaryotes,  though not in fungi. Pol θ is encoded by the POLQ gene in mammalian cells. The  C-terminal third of the protein is a family A DNA polymerase with additional, Context: insertion elements relative to prokaryotic homologs. The N-terminal third is a  helicase-like domain with DNA-dependent ATPase activity. Pol θ is important in  the repair of genomic double-strand breaks (DSBs) from many sources. These, Context: DNA polymerase theta (pol θ) is an evolutionarily conserved protein encoded by  the POLQ gene in mammalian genomes. Pol θ is the defining enzyme for a pathway  of DSB repair termed ""alternative end-joining"" (altEJ) or ""theta-mediated, Context: DNA polymerase theta (pol θ) is an evolutionarily conserved protein encoded by  the POLQ gene in mammalian genomes. Pol θ is the defining enzyme for a pathway  of DSB repair termed ""alternative end-joining"" (altEJ) or ""theta-mediated, Context: DNA polymerase theta (pol θ) is an evolutionarily conserved protein encoded by  the POLQ gene in mammalian genomes. Pol θ is the defining enzyme for a pathway  of DSB repair termed ""alternative end-joining"" (altEJ) or ""theta-mediated, Context: DNA polymerase theta (pol θ) is encoded in the genomes of many eukaryotes,  though not in fungi. Pol θ is encoded by the POLQ gene in mammalian cells. The  C-terminal third of the protein is a family A DNA polymerase with additional","27264557, 27264557, 28668117, 28668117, 28668117, 27264557",DNA polymerase theta (pol θ) is an evolutionarily conserved protein encoded by the POLQ gene in mammalian genomes,"27264557, 28668117"
Which lncRNAS are regulated by SAM68?,"Yes, Hotair, Mir155hg, SR-lncRNA-1, and SR-lncRNA-2 are regulated by Sam68. This information is provided in the context where it mentions that","Context: lncRNAs, we identified Hotair, Mir155hg, as well as two new lncRNAs (SR-lncRNA-1  and SR-lncRNA-2) that were regulated by Sam68, and contained consensus Sam68  binding sites. RNA stability assays showed that Sam68-deficiency decreased the, Context: depletion of SR-lncRNA-2 in Sam68-deficient 3T3-L1 cells partially rescued the  adipogenesis defect observed in these cells. Collectively, our findings define a  new role for Sam68 as a regulator of lncRNAs during adipogenic differentiation., Context: depletion of SR-lncRNA-2 in Sam68-deficient 3T3-L1 cells partially rescued the  adipogenesis defect observed in these cells. Collectively, our findings define a  new role for Sam68 as a regulator of lncRNAs during adipogenic differentiation., Context: depletion of SR-lncRNA-2 in Sam68-deficient 3T3-L1 cells partially rescued the  adipogenesis defect observed in these cells. Collectively, our findings define a  new role for Sam68 as a regulator of lncRNAs during adipogenic differentiation., Context: depletion of SR-lncRNA-2 in Sam68-deficient 3T3-L1 cells partially rescued the  adipogenesis defect observed in these cells. Collectively, our findings define a  new role for Sam68 as a regulator of lncRNAs during adipogenic differentiation., Context: depletion of SR-lncRNA-2 in Sam68-deficient 3T3-L1 cells partially rescued the  adipogenesis defect observed in these cells. Collectively, our findings define a  new role for Sam68 as a regulator of lncRNAs during adipogenic differentiation.","29137239, 29137239, 29137239, 29137239, 29137239, 29137239","Hotair, Mir155hg, as well as SR-lncRNA-1 and SR-lncRNA-2 are regulated by Sam68, and contained consensus Sam68 binding sites.",29137239
What is ectopia lentis?,"Ectopia lentis is a condition characterized by the subluxation of the lens due to the disruption of the zonular fibers. It can either be associated with systemic conditions or occur in isolation, and it leads","Context: Ectopia lentis (EL) is a condition that can either herald underlying systemic  conditions, or be isolated. The recent expansion in the genetics of these  conditions has furthered the understanding of the underlying molecular, Context: for a correlation of R240C and isolated ectopia lentis. In addition, this is the  first report of molecular characterization in an ectopia lentis family of Indian  origin., Context: Ectopia lentis (EL) is a zonular disease where alteration of the zonular fibers  leads progressively to lens dislocation. It is most often associated with  systemic diseases such as Marfan syndrome, Weill-Marchesani syndrome or, Context: Ectopia lentis is a genetically heterogeneous condition that is characterized by  the subluxation of the lens resulting from the disruption of the zonular fibers.  Patients with ectopia lentis commonly present with a marked loss in visual, Context: Ectopia lentis is a genetically heterogeneous condition that is characterized by  the subluxation of the lens resulting from the disruption of the zonular fibers.  Patients with ectopia lentis commonly present with a marked loss in visual, Context: Ectopia lentis is a genetically heterogeneous condition that is characterized by  the subluxation of the lens resulting from the disruption of the zonular fibers.  Patients with ectopia lentis commonly present with a marked loss in visual","24406422, 18079676, 20141359, 19200529, 19200529, 19200529",Ectopia Lentis is dislocation of the optic lens in the eye.,"25939784, 19200529, 25797933"
Describe RIblast,"Yes, RIblast is a sequence similarity search tool that achieves a level of prediction accuracy similar to existing programs but at significantly faster speeds. It is an open-source program, and its source code is freely available. RIbl","Context: essential for hypoxic survival in M. tuberculosis, but it is not known how the  regulon promotes survival. Here we report that mycobacteria, in contrast to  enteric bacteria, do not form higher-order structures (e.g. ribosomal dimers), Context: RIblast achieves a level of prediction accuracy similar to those of existing  programs, but at speeds over 64 times faster than existing programs. AVAILABILITY AND IMPLEMENTATION: The source code of RIblast is freely available, Context: RIblast achieves a level of prediction accuracy similar to those of existing  programs, but at speeds over 64 times faster than existing programs. AVAILABILITY AND IMPLEMENTATION: The source code of RIblast is freely available, Context: RIblast achieves a level of prediction accuracy similar to those of existing  programs, but at speeds over 64 times faster than existing programs. AVAILABILITY AND IMPLEMENTATION: The source code of RIblast is freely available, Context: RIblast achieves a level of prediction accuracy similar to those of existing  programs, but at speeds over 64 times faster than existing programs. AVAILABILITY AND IMPLEMENTATION: The source code of RIblast is freely available, Context: RIblast achieves a level of prediction accuracy similar to those of existing  programs, but at speeds over 64 times faster than existing programs. AVAILABILITY AND IMPLEMENTATION: The source code of RIblast is freely available","22544737, 28459942, 28459942, 28459942, 28459942, 28459942","LncRNAs play important roles in various biological processes. Although more than 58 000 human lncRNA genes have been discovered, most known lncRNAs are still poorly characterized. One approach to understanding the functions of lncRNAs is the detection of the interacting RNA target of each lncRNA. Because experimental detections of comprehensive lncRNA-RNA interactions are difficult, computational prediction of lncRNA-RNA interactions is an indispensable technique. However, the high computational costs of existing RNA-RNA interaction prediction tools prevent their application to large-scale lncRNA datasets. 'RIblast' is an ultrafast RNA-RNA interaction prediction method based on the seed-and-extension approach. RIblast discovers seed regions using suffix arrays and subsequently extends seed regions based on an RNA secondary structure energy model. Computational experiments indicate that RIblast achieves a level of prediction accuracy similar to those of existing programs, but at speeds over 64 times faster than existing programs.",28459942
Are piRNAs involved in gene silencing?,"Yes, according to the context, piRNAs are indeed involved in gene silencing. They play a role in a posttranscriptional gene-silencing mechanism that results in RNA nuclear accumulation. Additionally, they protect essential genes from","Context: piRNAs have investigated piRNA-mediated gene silencing, including piRNA  biogenesis. However, piRNAs remain the most enigmatic among all of the  silencing-inducing small RNAs because of their complexity and uniqueness., Context: transcripts are transported toward the oocyte where retrotransposition occurs.  Our results indicate that piRNAs are involved in a posttranscriptional  gene-silencing mechanism resulting in RNA nuclear accumulation., Context: RNAi, we uncovered a role for piRNAs in protecting essential genes from RNA  silencing., Context: RNAi, we uncovered a role for piRNAs in protecting essential genes from RNA  silencing., Context: RNAi, we uncovered a role for piRNAs in protecting essential genes from RNA  silencing., Context: piRNAs silence foreign genes, such as transposons, to preserve genome integrity,  but they also target endogenous mRNAs by mechanisms that are poorly understood.  Caenorhabditis elegans piRNAs interact with both transposon and nontransposon","23124062, 18809914, 26279487, 26279487, 26279487, 26279487",Piwi induces piRNA-guided transcriptional silencing and establishment of a repressive chromatin state. piRNA-guided slicing of transposon transcripts enforces their transcriptional silencing via specifying the nuclear piRNA repertoire. Transcriptional silencing implies a piRNA-mediated formation of repressive chromatin which diminishes the transcriptional capacity of the target locus.,"24178563, 20439430, 25336588, 21775629, 23625890, 21764773, 25842866, 18809914, 20559422, 26279487, 23465540, 20080197, 26302790, 26472911, 23124062, 23392610, 24939875, 23132912, 25313140, 24288375, 17872506"
Give an overview of visualizing genomes with oligopaint FISH probes.,"Yes, oligopaint FISH probes are a powerful tool for visualizing genomes. They are single-stranded DNA oligonucleotides that are fluorescently labeled and can be used to label genomic regions","Context: Oligopaint probes are fluorescently labeled, single-stranded DNA  oligonucleotides that can be used to visualize genomic regions ranging in size  from tens of kilobases to many megabases. This unit details how Oligopaint, Context: Oligopaint probes are fluorescently labeled, single-stranded DNA  oligonucleotides that can be used to visualize genomic regions ranging in size  from tens of kilobases to many megabases. This unit details how Oligopaint, Context: technologies reconstruct intermolecular interactions, others have enhanced our  ability to visualize chromosomes in situ. Here, we describe an oligonucleotide-  and PCR-based strategy for fluorescence in situ hybridization (FISH) and a, Context: bioinformatic platform that enables this technology to be extended to any  organism whose genome has been sequenced. The oligonucleotide probes are  renewable, highly efficient, and able to robustly label chromosomes in cell, Context: efforts there still exists a shortage of tools dedicated to visualizing the  genome. Creating a tool that can accurately visualize the genome can aid  researchers by highlighting structural relationships that may not be obvious, Context: when examining the sequence information alone. Here we present a desktop  application, known as GMOL, designed to effectively visualize genome structures  so that researchers may better analyze genomic data. GMOL was developed based","24510436, 24510436, 23236188, 23236188, 26868282, 26868282","Oligopaint probes are fluorescently labeled, single-stranded DNA oligonucleotides that can be used to visualize genomic regions ranging in size from tens of kilobases to many megabases. Coupled with fluorescence in situ hybridization (FISH) and a bioinformatic platform, this technology could be extended to any organism whose genome has been sequenced. The oligonucleotide probes are renewable, highly efficient, and able to robustly label chromosomes in cell culture, fixed tissues, and metaphase spreads. The method gives researchers precise control over the sequences they target and allows for single and multicolor imaging of chromosomal regions. It is anticipated that this technology will lead to an enhanced ability to visualize interphase and metaphase chromosomes.","24510436, 23236188"
What is the minimal genome build?,"No, the context does not provide information on what the minimal genome build is. The text discusses the concept of a minimal genome and the challenges in identifying it, but it does not specify what the actual genetic composition of such a minimal gen","Context: minimal genome and the potential applications are introduced., Context: A central undertaking in synthetic biology (SB) is the quest for the 'minimal  genome'. However, 'minimal sets' of essential genes are strongly  context-dependent and, in all prokaryotic genomes sequenced to date, not a, Context: functioning minimal genomes in naturally occurring microorganisms, which can  then be used as a template for future systems. Currently a prototypical minimal  genome has not been discovered. This review analyzes the organisms Mycoplasma, Context: single protein-coding gene is entirely conserved. Furthermore, a lack of  consensus in the field as to what attributes make a gene truly essential adds  another aspect of variation. Thus, a universal minimal genome remains elusive., Context: single protein-coding gene is entirely conserved. Furthermore, a lack of  consensus in the field as to what attributes make a gene truly essential adds  another aspect of variation. Thus, a universal minimal genome remains elusive., Context: compares them to the current minimal cell model in order to determine which most  closely resembles a true minimal genome. M. pneumoniae possesses a genome of 816  394 base pairs (bp) with 688 open reading frames (ORF) and a severely limited","22916492, 23219343, 21987714, 23219343, 23219343, 21987714","The identification of the essential genes of bacteria and the minimal genome for the free-living cellular life could provide insights into the origin, evolution, and essence of life forms. The field of Synthetic Biology seeks to apply engineering principles to biology in order to produce novel biological systems. One approach to accomplish this goal is the genome-driven cell engineering approach, which searches for functioning minimal genomes in naturally occurring microorganisms, which can then be used as a template for future systems. Currently a prototypical minimal genome has not been discovered.","21987714, 23420643, 23873957, 26539175, 22916492, 23219343, 21203957"
Which histone marks are deposited by Set7?,"Yes, Set7 deposits methyl marks on histones. Specifically, it is known to monomethylate lysine 4 of histone H3 (H3K4me1) and lysine 20","Context: active gene transcription in meiotic and post-meiotic cells. In addition,  H4K8ac-associated genes are included in and constitute only a subfraction of  H4K8hib-labeled genes. The histone Khib mark is conserved and widely, Context: We describe distinct patterns of histone methylation during human cell cycle  progression. Histone H4 methyltransferase activity was found to be cell  cycle-regulated, consistent with increased H4 Lys 20 methylation at mitosis., Context: histone methyltransferase PR-Set7. PR-Set7 depletion in mammalian cells results  in defective S phase progression and the accumulation of DNA damage, which has  been partially attributed to defects in origin selection and activation., Context: histone methyltransferase PR-Set7. PR-Set7 depletion in mammalian cells results  in defective S phase progression and the accumulation of DNA damage, which has  been partially attributed to defects in origin selection and activation., Context: Methylation of lysine residues of histones is an important epigenetic mark that  correlates with functionally distinct regions of chromatin. We present here the  crystal structure of a ternary complex of the enzyme Pr-Set7 (also known as, Context: the N-terminus of histone H3. In addition, the SET7/9 assay was demonstrated  using full-length histone H3 protein as substrate in the AlphaLISA format.  Optimized assays in 384-well plates are robust (Z' factors ≥0.7) and sensitive,","24681537, 12208845, 27131378, 27131378, 15933069, 21940714",Set7 is H4K20 monomethyltransferase. Upregulation of PR-Set7 expression upon loss of HCF-1 leads to improper mitotic H4-K20 methylation. Set7 (or some variant) has also been reported to perform mono-methylation on lysine-4 of H3.,"21963854, 12086618, 12208845, 15200950"
What is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?,"No, the context does not provide information on the most common monogenic cause of CVID in Europeans.","Context: Common variable immunodeficiency (CVID) is a heterogeneous group of diseases.  Our aim was to define sub-groups of CVID patients with similar phenotypes and  clinical characteristics. Using eight-color flow cytometry, we analyzed both B-, Context: BACKGROUND: Evans syndrome (ES) is a rare immune disorder in children,  manifested by simultaneous or sequential autoimmune cytopenias (ACs) of unknown  cause and having a chronic course with periods of exacerbation and remission., Context: Common variable immunodeficiency (CVID) is a heterogeneous group of diseases.  Our aim was to define sub-groups of CVID patients with similar phenotypes and  clinical characteristics. Using eight-color flow cytometry, we analyzed both B-, Context: variable immunodeficiency (CVID). MATERIALS AND METHODS: Review of clinical charts and laboratory results of  pediatric patients followed-up in the outpatient clinic of PID with a diagnosis  of ES and humoral immunodeficiency., Context: variable immunodeficiency (CVID). MATERIALS AND METHODS: Review of clinical charts and laboratory results of  pediatric patients followed-up in the outpatient clinic of PID with a diagnosis  of ES and humoral immunodeficiency., Context: Some primary immunodeficiencies (PIDs) may present with autoimmune  manifestations without infections, masking suspicion of them. The PIDs that can  typically manifest as ES are autoimmune lymphoproliferative syndrome and common","28054583, 28937520, 28054583, 28937520, 28937520, 28937520",Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.,"29477724, 30063981"
What are the targets of pemigatinib?,"Yes, pemigatinib is a small molecule inhibitor that targets fibroblast growth factor receptor (FGFR) 1, FGFR2, and FGFR3. This information is explicitly stated in the","Context: various countries worldwide for use in several other FGFR-driven malignancies  (e.g. solid tumour, urothelial carcinoma). This article summarizes the  milestones in the development of pemigatinib leading to this first approval for, Context: for the treatment of myeloid/lymphoid neoplasms with eosinophilia and  rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 in August 2019 in  the USA. A regulatory assessment for pemigatinib as a treatment for adults with, Context: (FGF) receptor 3 (FGFR3) as a molecular mechanism responsible for trastuzumab  resistance in GC models, providing the rationale for the inhibition of this  receptor as a potential second-line strategy in this disease. Pemigatinib is a, Context: analyses at baseline, during treatment, and at progression on pemigatinib. DISCUSSION: Co-alterations in genes coding for different tyrosine-kinase  receptors are emerging as relevant mechanisms of acquired resistance to, Context: analyses at baseline, during treatment, and at progression on pemigatinib. DISCUSSION: Co-alterations in genes coding for different tyrosine-kinase  receptors are emerging as relevant mechanisms of acquired resistance to, Context: Pemigatinib (PEMAZYRE™), a small molecule inhibitor of fibroblast growth factor  receptor (FGFR) 1, FGFR2 and FGFR3, received accelerated approval in April 2020  in the USA for the treatment of adults with previously treated, unresectable,","32472305, 32472305, 32684989, 32684989, 32684989, 32472305","Pemigatinib is a small molecule inhibitor of fibroblast growth factor receptor (FGFR) 1, FGFR2 and FGFR3, received accelerated approval  for the treatment of adults with previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma and a FGFR2 fusion or other rearrangement, as detected by a US FDA-approved test.","32677452, 32472305, 32203698, 32315352, 32684989"
Which de novo mutation in FGFR cause achondroplasia?,"Yes, a de novo mutation in exon 10 of the FGFR3 gene causing a glycine to arginine substitution at position 380 (Gly380Arg) is commonly associated","Context: OBJECTIVE: To evaluate whether mutation in the exon 10 of the fibroblast growth  factor receptor 3(FGFR3) gene in common in Chinese patients with achondroplasia. METHODS: Genomic DNA from seven sporadic cases of achondroplasia was studied by, Context: and Crouzon syndrome with acanthosis nigricans. Recent evidence suggests that  the phenotypic differences may be due to specific alleles with varying degrees  of ligand-independent activation, allowing the receptor to be constitutively, Context: frequent mutation causing achondroplasia in Chinese. Detecting FGFR 3 gene  mutation with PCR-SSCP and restriction enzymes analysis is a convenient, rapid  and reliable molecular diagnostic assay for prenatal and early diagnosis of  achondroplasia., Context: frequent mutation causing achondroplasia in Chinese. Detecting FGFR 3 gene  mutation with PCR-SSCP and restriction enzymes analysis is a convenient, rapid  and reliable molecular diagnostic assay for prenatal and early diagnosis of  achondroplasia., Context: active. Since the Gly380Arg achondroplasia mutation was recognized, similar  observations regarding the conserved nature of FGFR mutations and resulting  phenotype have been made regarding other skeletal phenotypes, including, Context: dimers. The data analysis presented here suggests that the mutation does not  increase FGFR3 dimerization, as proposed previously. Instead, FGFR3 activity in  achondroplasia is increased due to increased probability for phosphorylation of","9949234, 10696568, 9949234, 9949234, 10696568, 20624921","Recurrent missense mutations in a CpG doublet of the transmembrane domain of the FGFR3 protein (glycine substituted with arginine at residue 380, G380R).",8078586
How do HBS1L-MYB intergenic variants regulate fetal hemoglobin?,"Yes, HBS1L-MYB intergenic variants regulate fetal hemoglobin by reducing transcription factor binding and affecting long-range interactions with MYB. This results in altered expression levels of MYB, which","Context: Genetic studies have identified common variants within the intergenic region  (HBS1L-MYB) between GTP-binding elongation factor HBS1L and myeloblastosis  oncogene MYB on chromosome 6q that are associated with elevated fetal hemoglobin, Context: (HbF) levels and alterations of other clinically important human erythroid  traits. It is unclear how these noncoding sequence variants affect multiple  erythrocyte characteristics. Here, we determined that several HBS1L-MYB, Context: Genetic studies have identified common variants within the intergenic region  (HBS1L-MYB) between GTP-binding elongation factor HBS1L and myeloblastosis  oncogene MYB on chromosome 6q that are associated with elevated fetal hemoglobin, Context: several HBS1L-MYB intergenic variants reduce transcription factor binding,  affecting long-range interactions with MYB and MYB expression levels. These data  provide a functional explanation for the genetic association of HBS1L-MYB, Context: intergenic variants affect regulatory elements that are occupied by key  erythroid transcription factors within this region. These elements interact with  MYB, a critical regulator of erythroid development and HbF levels. We found that, Context: Fetal hemoglobin (HbF), the predominant hemoglobin in the fetus, is a mixture of  two molecular species (alpha(2)(G)gamma(2) and alpha(2)(A)gamma(2)) that differ  only at position 136 reflecting the products of two nonallelic gamma-globin","24614105, 24614105, 24614105, 24614105, 24614105, 18379999","HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers. Several HBS1L-MYB intergenic variants affect regulatory elements that are occupied by key erythroid transcription factors within this region. These elements interact with MYB, a critical regulator of erythroid development and HbF levels. Several HBS1L-MYB intergenic variants reduce transcription factor binding, affecting long-range interactions with MYB and MYB expression levels.",24614105
Does TIMELESS-TIPIN participate in replisome disassembly?,"Yes, based on the context provided, TIMELESS-TIPIN is involved in replisome disassembly. The text explicitly states that UBXN-3 is important for replisome disassembly in the absence of TIMELESS","Context: CMG by CDC-48_UFD-1_NPL-4. We show that UBXN-3 is important in vivo for  replisome disassembly in the absence of TIMELESS-TIPIN. Correspondingly,  co-depletion of UBXN-3 and TIMELESS causes profound synthetic lethality. Since, Context: p97/CDC-48 ""unfoldase"". Here, we combine in vitro reconstitution with in vivo  studies in Caenorhabditis elegans embryos, to show that the replisome-associated  TIMELESS-TIPIN complex is required for CUL-2LRR-1 recruitment and efficient CMG, Context: CMG by CDC-48_UFD-1_NPL-4. We show that UBXN-3 is important in vivo for  replisome disassembly in the absence of TIMELESS-TIPIN. Correspondingly,  co-depletion of UBXN-3 and TIMELESS causes profound synthetic lethality. Since, Context: CMG by CDC-48_UFD-1_NPL-4. We show that UBXN-3 is important in vivo for  replisome disassembly in the absence of TIMELESS-TIPIN. Correspondingly,  co-depletion of UBXN-3 and TIMELESS causes profound synthetic lethality. Since, Context: CMG by CDC-48_UFD-1_NPL-4. We show that UBXN-3 is important in vivo for  replisome disassembly in the absence of TIMELESS-TIPIN. Correspondingly,  co-depletion of UBXN-3 and TIMELESS causes profound synthetic lethality. Since, Context: CMG by CDC-48_UFD-1_NPL-4. We show that UBXN-3 is important in vivo for  replisome disassembly in the absence of TIMELESS-TIPIN. Correspondingly,  co-depletion of UBXN-3 and TIMELESS causes profound synthetic lethality. Since","34269473, 34269473, 34269473, 34269473, 34269473, 34269473",Yes. TIMELESS-TIPIN and UBXN-3 promote replisome disassembly during DNA replication termination in Caenorhabditis elegans.,34269473
Is avelumab effective for bladder cancer?,"Yes, avelumab is effective for bladder cancer. It is one of the novel therapeutic advances that have gained approval by the FDA for treatment of bladder cancer, as mentioned in the context.","Context: in bladder cancer therapeutics have rejuvenated the field. Nivolumab,  pembrolizumab, atezolizumab, durvalumab, and avelumab are among the exciting  recent novel therapeutic advances gaining approvals by the FDA for treatment of, Context: This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN  Guidelines) for Bladder Cancer focuses on systemic therapy for muscle-invasive  urothelial bladder cancer, as substantial revisions were made in the 2017, Context: in bladder cancer therapeutics have rejuvenated the field. Nivolumab,  pembrolizumab, atezolizumab, durvalumab, and avelumab are among the exciting  recent novel therapeutic advances gaining approvals by the FDA for treatment of, Context: in bladder cancer therapeutics have rejuvenated the field. Nivolumab,  pembrolizumab, atezolizumab, durvalumab, and avelumab are among the exciting  recent novel therapeutic advances gaining approvals by the FDA for treatment of, Context: updates, such as new recommendations for nivolumab, pembrolizumab, atezolizumab,  durvalumab, and avelumab. The complete version of the NCCN Guidelines for  Bladder Cancer addresses additional aspects of the management of bladder cancer,, Context: updates, such as new recommendations for nivolumab, pembrolizumab, atezolizumab,  durvalumab, and avelumab. The complete version of the NCCN Guidelines for  Bladder Cancer addresses additional aspects of the management of bladder cancer,","29784744, 28982750, 29784744, 29784744, 28982750, 28982750","Yes, avelumab is effective treatment of bladder cancer.","29103968, 29606979, 29784744, 29644490, 28864844, 28493171, 29540084, 29069302, 28214651, 29416316, 28982750"
What is the purpose of the Tokuhashi scoring system?,"Yes, the purpose of the Tokuhashi scoring system is to predict the prognosis of spinal metastases after operation and to foresee early death more accurately. This can be used to avoid major operations for patients with a high risk","Context: underestimated the prognosis in scores from 0 to 8. CONCLUSIONS: Both Tomita and Tokuhashi scoring systems could be used to predict  prognosis of spinal metastases after operation. Tokuhashi scoring system can, Context: predict early death more accurately, which can be used to avoid major operation  for these patients., Context: The new AIS (Abbreviated Injury Scale) was released with an update by the AAAM  (Association for the Advancement of Automotive Medicine) in 2008. It is a  universal scoring system in the field of trauma applicable in clinic and, Context: score, and Katagiri score were introduced. They are all scoring systems prepared  by combining factors that affect prognosis. The primary site of cancer and  visceral metastasis were common factors in all of these scoring systems. Other, Context: system reclassified all patients except one in the correct direction. In most  cases, the observed incidence of death in patients who were reclassified matched  what would have been predicted by the GAP scoring system., Context: cumulative recurrence and progression rates were calculated. RESULTS: A scoring system was calculated with a score of 0 to 16 for recurrence  and 0 to 14 for progression. Patients were categorized into 4 groups by score,","17094910, 17094910, 20376615, 25035829, 21831280, 19758621",Tokuhashi scoring system was developed to predict life expectancy of patients with spinal metastases. The revised Tokuhashi score has been widely used to evaluate indications for surgery and predict survival in patients with metastatic spinal disease.,"25085251, 24212518, 22973387, 23328875, 21772622, 17593839, 21223698, 25035829, 21796024, 17094910"
HER-2 belongs to what family of proteins?,"Yes, HER-2/neu belongs to the EGFR (Epidermal Growth Factor Receptor) family of proteins. This is explicitly stated in the context information provided. The EGFR family is a group","Context: Metastatic breast cancer is an incurable disease in a very high percentage of  patients. Despite new progress in endocrine and other systemic therapies, this  evidence remains challenging for patients and clinicians. HER2 protein is a, Context: HER-2/neu, also known as c-erbB-2/neu, is an oncogene located in chromosome 17  which encodes HER-2/neu, a transmembrane protein belonging to the EGFR family.  The external domain of this protein is released by the cell and can be studied, Context: Her-2/neu belongs to the family of tyrosine kinase transmembrane proteins whose  overexpression has been associated with a poor prognosis in patients with breast  cancer. The product of this proto-oncogene is overexpressed in 25-30% of human, Context: HER-2/neu, also known as c-erbB-2/neu, is an oncogene located in chromosome 17  which encodes HER-2/neu, a transmembrane protein belonging to the EGFR family.  The external domain of this protein is released by the cell and can be studied, Context: HER-2/neu, also known as c-erbB-2/neu, is an oncogene located in chromosome 17  which encodes HER-2/neu, a transmembrane protein belonging to the EGFR family.  The external domain of this protein is released by the cell and can be studied, Context: HER-2/neu, also known as c-erbB-2/neu, is an oncogene located in chromosome 17  which encodes HER-2/neu, a transmembrane protein belonging to the EGFR family.  The external domain of this protein is released by the cell and can be studied","16800251, 22505536, 11785652, 22505536, 22505536, 22505536",Her-2 belongs to the family of the human epidermal growth factor receptors (EGFRs).,"16707458, 26545934, 15173008, 27993109, 30312728, 15920544, 21896992, 33202212, 11785652, 17536308, 15782071, 11694782, 22505536, 17867585, 12767812, 25620423, 27426127, 30384340, 10480346, 11180765, 19048033, 7612897, 21805036, 19279475, 29389942, 16800251, 18505086"
Which is the protein encoded by the human gene GRIK?,"Yes, the human gene GRIK3 encodes a glutamate receptor ionotropic kainate","Context: The gene of 4.4 kb is composed of five exons, and the structure is 90% similar  to that of the orthologous human gene. It gives rise to a polypeptide of 261  amino acids, including a signal peptide of 17 residues, a pro-piece of 7, Context: Herein, we report on a girl who presented with a severe developmental delay  predominantly affecting her language and fine motor skills. She had a 2.6-Mb  microdeletion in 1p34.3 involving GRIK3, which encodes a principal subunit of, Context: The human Transducin-like Enhancer of Split (TLE) and mouse homologue, Groucho  gene-related protein (GRG), represent a family of conserved non-DNA binding  transcriptional modulatory proteins divided into two subgroups based upon size., Context: revealed that Grg is a 25 kd nuclear protein that can participate in specific  protein-protein interactions. A null mutation of the Grg gene was constructed by  gene targeting. Mice homozygous for this mutation completed embryogenesis and, Context: for a complete Groucho protein homologue. The second transcript contains coding  sequence for only the two amino-terminal domains of the Groucho protein,  followed by a hydrophobic tail and a stop codon. We analyzed the expression of, Context: The murine grg (Groucho-related gene) products are believed to interact with  transcription factors and repress transcription, thereby regulating cell  proliferation and differentiation. Most proteins in the grg family contain all","11177570, 24449200, 20925119, 8573724, 8989517, 8955148",Glutamate Receptor Ionotropic Kainate,"24449200, 22291662"
Which company developed eptinezumab?,"Yes, Lundbeck Seattle BioPharmaceuticals developed eptinezumab. This is stated explicitly in the context when it mentions that ""eptinezumab, delivered by intravenous (IV) administration, is","Context: Biopharma, Pharmacyclics, Gilead, Genentech, TG Therapeutics, Bigene, Acerta,  Emergent, and Merck. A.K.G. reports grants and nonfinancial support from Teva,  Bristol-Myers Squibb, Merck, Takeda, TG Therapeutics, and Effector; grants,, Context: Eptinezumab-jjmr (referred to as eptinezumab hereafter; Vyepti™) is a humanised  monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and  blocks its binding to the receptor. CGRP is believed to play a major role in the, Context: pathophysiology of migraine. Eptinezumab, delivered by intravenous (IV)  administration, is being developed by Lundbeck Seattle BioPharmaceuticals for  the prevention of migraine. In February 2020, eptinezumab was approved in the, Context: USA for the preventive treatment of migraine in adults. This article summarizes  the milestones in the development of eptinezumab leading to this first approval., Context: METHODS: Patients received up to two 30-min IV administrations of eptinezumab  100 mg, 300 mg, or placebo separated by 12 weeks. Patients recorded migraine and  headache endpoints in a daily eDiary. Additional assessments, including, Context: RESULTS: A total of 1072 adults received treatment: eptinezumab 100 mg, n = 356;  eptinezumab 300 mg, n = 350; placebo, n = 366. The reduction in mean monthly  migraine days observed during the first dosing interval (100 mg, - 7.7 days;","29914976, 32266704, 32266704, 32266704, 33023473, 33023473",Eptinezumab was developed by Lundbeck Seattle BioPharmaceuticals.,32266704
What is the route of administration of eptinezumab?,"Yes, the route of administration of eptinezumab is by intravenous (IV) infusion. This information was provided in the context as it mentioned that eptinezumab is delivered by intravenous (IV)","Context: pathophysiology of migraine. Eptinezumab, delivered by intravenous (IV)  administration, is being developed by Lundbeck Seattle BioPharmaceuticals for  the prevention of migraine. In February 2020, eptinezumab was approved in the, Context: USA for the preventive treatment of migraine in adults. This article summarizes  the milestones in the development of eptinezumab leading to this first approval., Context: pathophysiology of migraine. Eptinezumab, delivered by intravenous (IV)  administration, is being developed by Lundbeck Seattle BioPharmaceuticals for  the prevention of migraine. In February 2020, eptinezumab was approved in the, Context: pathophysiology of migraine. Eptinezumab, delivered by intravenous (IV)  administration, is being developed by Lundbeck Seattle BioPharmaceuticals for  the prevention of migraine. In February 2020, eptinezumab was approved in the, Context: pathophysiology of migraine. Eptinezumab, delivered by intravenous (IV)  administration, is being developed by Lundbeck Seattle BioPharmaceuticals for  the prevention of migraine. In February 2020, eptinezumab was approved in the, Context: pathophysiology of migraine. Eptinezumab, delivered by intravenous (IV)  administration, is being developed by Lundbeck Seattle BioPharmaceuticals for  the prevention of migraine. In February 2020, eptinezumab was approved in the","32266704, 32266704, 32266704, 32266704, 32266704, 32266704",Eptinezumab is administered intravenously.,32266704
Can the apoptosis regulator BAX trigger the release of cytochrome c?,"Yes, based on the context information provided, BAX can indeed trigger the release of cytochrome c. This is mentioned explicitly in the text when it states that ""induced Bax translocation to cause cytochrome c release"" and also","Context: induced Bax translocation to cause cytochrome c release. Subsequently, caspase-9  and caspase-3 were activated. Meanwhile, the alterations of cyclin A and B1,  p-CDK1 and p-cdc25c levels were also observed in response to DICO treatment., Context: cells. CsA increased the number of living cells in cell culture, as compared  with the effect of Bax channel blocker. These results indicate that mPTP  activation is the predominant pathway for Bax-induced cytochrome c release from, Context: domain, oligomerized, and released cytochrome c. Despite this Bax-like  subcellular distribution, Bak/BaxCS retained Bak-like regulation following  targeting of Mcl-1. CONCLUSIONS/SIGNIFICANCE: Residues in the C-segment of Bak and of Bax contribute, Context: domain, oligomerized, and released cytochrome c. Despite this Bax-like  subcellular distribution, Bak/BaxCS retained Bak-like regulation following  targeting of Mcl-1. CONCLUSIONS/SIGNIFICANCE: Residues in the C-segment of Bak and of Bax contribute, Context: induced Bax translocation to cause cytochrome c release. Subsequently, caspase-9  and caspase-3 were activated. Meanwhile, the alterations of cyclin A and B1,  p-CDK1 and p-cdc25c levels were also observed in response to DICO treatment., Context: effect of such compounds in apoptosis induction via mPTP or Bax oligomerization.  Cytochrome c release was totally prevented by CsA and partially by Bcb when  apoptosis was induced with recombinant Bax in isolated mitochondria from MCF7","23567243, 23536162, 22442658, 22442658, 23567243, 23536162","Yes, altered Bax conformation trigger its redistribution from the cytosol to mitochondria. Subsequently, cytochrome c is released from mitochondria to cytosol.","25116390, 23567751, 22116711, 23954445, 25524600, 25619640, 21307199"
How is Hsd17b1 associated with endometriosis?,"Yes, HSD17B1 is associated with an increased risk of endometriosis. Specifically, in a Japanese population, individuals with the A/G or A/A genotypes of HSD17B1 had higher","Context: HSD17B1 showed a significantly increased risk of endometriosis (A/G genotype:  adjusted OR, 3.06; 95%CI 1.21-7.74; A/A genotype: adjusted OR, 3.02; 95%CI  1.08-8.43). There was a significant trend associating A/G + A/A genotypes with, Context: HSD17B1 and endometriosis was found in a Japanese population. The A-allele of  HSD17B1 appears to confer higher risk for endometriosis., Context: HSD17B1 and endometriosis was found in a Japanese population. The A-allele of  HSD17B1 appears to confer higher risk for endometriosis., Context: HSD17B1 and endometriosis was found in a Japanese population. The A-allele of  HSD17B1 appears to confer higher risk for endometriosis., Context: HSD17B1 and endometriosis was found in a Japanese population. The A-allele of  HSD17B1 appears to confer higher risk for endometriosis., Context: HSD17B1 showed a significantly increased risk of endometriosis (A/G genotype:  adjusted OR, 3.06; 95%CI 1.21-7.74; A/A genotype: adjusted OR, 3.02; 95%CI  1.08-8.43). There was a significant trend associating A/G + A/A genotypes with","15640252, 15640252, 15640252, 15640252, 15640252, 15640252",Evidence for association between the Ser312Gly polymorphism in HSD17B1 and endometriosis was found in a Japanese population. The A-allele of HSD17B1 appears to confer higher risk for endometriosis.  Inhibition of the estradiol-synthesizing enzyme 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) has been proposed as a promising new therapeutic option to treat estrogen-dependent diseases like endometriosis,"15640252, 19014997"
Is the long non- coding RNA malat-1 up or downregulated in cancer?,"Yes, malat-1 is upregulated in some cancers. The given context states that MALAT-1 expression is upregulated in bladder cancer tissues and other tumors.","Context: histology specific. The Kaplan-Meier analyses identified MALAT-1 and thymosin  beta4 as prognostic parameters for patient survival in stage I NSCLC. The novel  MALAT-1 transcript is a noncoding RNA of more than 8000 nt expressed from, Context: cancer metastasis remain largely unknown. In the present study we evaluated  MALAT-1 expression in bladder cancer tissues by real-time PCR, and defined its  biological functions. We verified that MALAT-1 levels were upregulated in, Context: Recent studies reveal that long non-coding RNAs (lncRNAs) have been shown to  have important regulatory roles in cancer biology, and lncRNA MALAT-1 expression  is upregulated in some tumors. However, the contributions of MALAT-1 to bladder, Context: Recent studies reveal that long non-coding RNAs (lncRNAs) have been shown to  have important regulatory roles in cancer biology, and lncRNA MALAT-1 expression  is upregulated in some tumors. However, the contributions of MALAT-1 to bladder, Context: The MALAT1 (metastasis-associated lung adenocarcinoma transcript 1) locus is  misregulated in many human cancers and produces an abundant long  nuclear-retained noncoding RNA. Despite being transcribed by RNA polymerase II,, Context: The long noncoding RNA MALAT1 (metastasis-associated lung adenocarcinoma  transcript 1), also known as MALAT-1 or NEAT2 (nuclear-enriched abundant  transcript 2), is a highly conserved nuclear noncoding RNA (ncRNA) and a","12970751, 22722759, 22722759, 22722759, 23073843, 23243023",Malat-1 expression is upregulated in several tumor types,"21266177, 16878148, 24163781, 22722759, 21678027, 16441420, 18006640, 23845456, 20007090, 22858678, 23726266, 15552795, 22088988, 12970751"
Does the 3D structure of  the genome remain stable during cell differentiation?,"No, the 3D structure of the genome is not stable during cell differentiation. According to the context, the 3D genome undergoes dynamic rearrangement during normal development and its structure changes during reprogramming and","Context: The 3D structure of chromatin plays a key role in genome function, including  gene expression, DNA replication, chromosome segregation, and DNA repair.  Furthermore the location of genomic loci within the nucleus, especially relative, Context: Chromatin structural states and their remodelling, including higher-order  chromatin folding and three-dimensional (3D) genome organisation, play an  important role in the control of gene expression. The role of 3D genome, Context: development. In this review, we discuss new insights into how the structural  features of the 3D genome hierarchy are established and maintained, how this  hierarchy undergoes dynamic rearrangement during normal development and how its, Context: structure during reprogramming and differentiation. In this review, we will  discuss the classical view and our renewed understanding of insulators as global  genome organizers. We will also discuss the plasticity of chromatin structure, Context: structure during reprogramming and differentiation. In this review, we will  discuss the classical view and our renewed understanding of insulators as global  genome organizers. We will also discuss the plasticity of chromatin structure, Context: and its re-organization during pluripotency and differentiation and in  situations of cellular stress.","29522506, 24346698, 29990539, 26340639, 26340639, 26340639","Many studies have suggested a link between the spatial organization of genomes and fundamental biological processes such as genome reprogramming, gene expression, and differentiation. The open chromatin of embryonic stem cells (ESCs) condenses into repressive heterochromatin as cells exit the pluripotent state. The relation between alterations in chromatin structure and changes in gene expression during cell differentiation has served as a paradigm to understand the link between genome organization and function. Insulators are involved in 3D genome organization at multiple spatial scales and are important for dynamic reorganization of chromatin structure during reprogramming and differentiation. Architectural proteins orchestrate higher-order chromatin organization through the establishment of interactions between regulatory elements across multiple spatial scales. The regulation of these proteins, their interaction with DNA, and their co-occurrence in the genome, may be responsible for the plasticity of 3D chromatin architecture that dictates cell and time-specific blueprints of gene expression.","22495300, 25479748, 26340639, 24346698, 23199754, 24905166, 25218583, 25693564, 24305663"
Are thyroid hormone receptor alpha1 mutations  implicated in thyroid hormone resistance syndrome?,"No, thyroid hormone receptor alpha1 mutations are not implicated in thyroid hormone resistance syndrome. According to the context, RTH is caused by mutations of the thyroid hormone receptor beta (TR beta) gene","Context: Resistance to thyroid hormone (RTH) is an inherited syndrome of reduced tissue  responsiveness to thyroid hormone. To date, all individuals expressing the RTH  phenotype have been found to harbor mutations in the thyroid hormone receptor, Context: Resistance to thyroid hormone (RTH) is caused by mutations of the thyroid  hormone receptor beta (TR beta) gene. Almost all RTH patients are heterozygous  with an autosomal dominant pattern of inheritance. That most are clinically, Context: Resistance to thyroid hormone (RTH) is caused by mutations of the thyroid  hormone receptor beta (TR beta) gene. Almost all RTH patients are heterozygous  with an autosomal dominant pattern of inheritance. That most are clinically, Context: Resistance to thyroid hormone (RTH) is caused by mutations of the thyroid  hormone receptor beta (TR beta) gene. Almost all RTH patients are heterozygous  with an autosomal dominant pattern of inheritance. That most are clinically, Context: Resistance to thyroid hormone (RTH) is caused by mutations of the thyroid  hormone receptor beta (TR beta) gene. Almost all RTH patients are heterozygous  with an autosomal dominant pattern of inheritance. That most are clinically, Context: RTH, mutation of the thyroid hormone receptor beta gene results in generalized  tissue resistance to thyroid hormone. As the pituitary gland shares in this  tissue resistance, euthyroidism with a normal thyroid-stimulating hormone is","8954015, 12750454, 12750454, 12750454, 12750454, 17040361",thyroid hormone receptor alpha1 mutations are implicated in thyroid hormone resistance syndrome,"23528896, 23633213, 12750454"
What is the drug target for Eliquis (Apixaban)?,"Yes, Apixaban, which is marketed as Eliquis, directly targets factor-Xa. This information is provided in the context as one of the new direct oral anticoagulants used for treating deep venous thrombosis","Context: IL-6 binding to its receptor complex. This review also summarizes the biologics  targeting either IL-6 or the IL-6 receptor, including tocilizumab, sarilumab,  sirukumab, olokizumab, clazakizumab, and siltuximab. The target, dosage,, Context: The new direct oral anticoagulants directly targeting thrombin (factor IIa) or  factor-Xa, are currently used for the treatment of deep venous thrombosis and  pulmonary embolism (rivaroxaban, Xarelto) or for the prevention of systemic, Context: strategy are described. A target database, termed TargetDB, was firstly  constructed, which contains 1105 drug targets. Based on TargetDB, the molecular  docking-based target prediction and pharmacophore-based target prediction, Context: possible drug target in, OA., Context: drugs currently in the pipeline for treating insomnia. Specifically, the authors  performed MEDLINE and internet searches using the keywords 'Phase II' and  'insomnia'. The drugs covered target GABAA (zaleplon-CR, lorediplon, EVT-201),, Context: embolism in non-valvular atrial fibrillation (rivaroxaban; dabigatran, Pradaxa;  Apixaban, Eliquis). Given their ease of use, it is expected that these drugs  would be widely used in such long-term indications. Beyond their effectiveness,","26392750, 24624626, 23933279, 24780007, 25423562, 24624626",The new oral anticoagulants (NOAC) Apixaban (Eliquis) is a direct anti-Xa inhibitors,"24711240, 23649961, 23535530, 23677804, 24624626, 21985171, 26095540, 28439702, 26369819, 27653758, 25322783"
What molecule is targeted by brodalumab?,"Yes, the context mentions the molecule targeted by brodalumab. Brodalumab targets the IL-17 receptor (IL-17R). It blocks IL-17A from binding to its receptor, which","Context: to the interteukin-4R is the first antibody (i.e. 'biological') with published  efficacy shown in controlled prospective studies in atopic dermatitis. A number  of other target molecules is currently addressed in clinical studies with, Context: providing clinicians with an overview of the next era in immunotherapy for  psoriasis., Context: ixekizumab - all target the IL-17 signaling pathway. Secukinumab and ixekizumab  neutralize IL-17A, while brodalumab blocks its receptor. Results from clinical  trials have shown marked improvements in disease severity in patients with, Context: ixekizumab - all target the IL-17 signaling pathway. Secukinumab and ixekizumab  neutralize IL-17A, while brodalumab blocks its receptor. Results from clinical  trials have shown marked improvements in disease severity in patients with, Context: this agent, as well as for several emerging therapies that target other cytokine  pathways in psoriasis: the IL-17 inhibitors secukinumab, ixekizumab, and  brodalumab, the IL-23 blocker tildrakizumab, and the small-molecule kinase, Context: this agent, as well as for several emerging therapies that target other cytokine  pathways in psoriasis: the IL-17 inhibitors secukinumab, ixekizumab, and  brodalumab, the IL-23 blocker tildrakizumab, and the small-molecule kinase","26308331, 25713988, 25246805, 25246805, 24979544, 24979544",Interleukin-17. Brodalumab is anti interleukin-17 monoclonal antibody.,"26422722, 25713988, 24918373, 25599143, 24200404, 25246805, 22455412, 24646743, 25093016, 24552447"
What do studies show about the effect of Induced hypothermia in premature babies?,"Yes, studies suggest that induced hypothermia could be beneficial for premature babies. While its efficacy has been demonstrated in animal experimental models, clinical application is currently limited to restricted cases. A study aimed to establish the feasibility and safety","Context: treatment to preterm newborns. Studies in animal experimental models  demonstrated the efficacy of hypothermia in preterm fetuses but clinical  application to newborn infants are limited to restricted cases, as severe, Context: necrotizing enterocolitis (NEC). We present a case of therapeutic whole body  cooling in a baby at 34 weeks and 6 days of gestational age with HIE., Context: INTRODUCTION: Randomised studies have demonstrated the efficacy of hypothermia  for the treatment of perinatal hypoxic-ischaemic encephalopathy (HIE) in term or  late preterm infants. In August 2006, the Neonatology Department at, Context: treatment to preterm newborns. Studies in animal experimental models  demonstrated the efficacy of hypothermia in preterm fetuses but clinical  application to newborn infants are limited to restricted cases, as severe, Context: infants with these conditions. We aimed to establish the feasibility and safety  of mild hypothermia in preterm neonates with NEC and MODS as a prelude to a  randomized trial., Context: Therapeutic hypothermia is a recognized treatment for term infants with  hypoxic-ischemic encephalopathy (HIE) in reducing rate of death or  neurodevelopmental disabilities. Little is known about applications of this","22320395, 22320395, 20470651, 22320395, 20100756, 22320395",Randomised studies have demonstrated the efficacy of hypothermia for the treatment of perinatal hypoxic-ischaemic encephalopathy (HIE)  in reducing rate of death or neurodevelopmental disabilities in term or late preterm infants. It remains unclear to what degree preterm infants were included in these studies. A prospective non-randomised pilot study reported that mild hypothermia for 48 hours in preterm neonates with severe NEC (necrotising enterocolitis) seems both feasible and safe.,"22320395, 20100756, 19020525, 20470651"
Which enzyme is targeted by the drug Imetelstat?,"Yes, the enzyme targeted by the drug Imetelstat is telomerase. This is explicitly stated in the context as ""the thio-phosphoramidate oligonucleotide inhibitor of telomer","Context: druggable targets including various related information such as protein, gene,  protein domain, protein structure, binding site, small molecule drug, mechanism  of action, protein tissue localization, disease association, and many other, Context: Telomerase is mainly active in human tumor cells, which provides an opportunity  for a therapeutic window on telomerase targeting. We sought to evaluate the  potential of the thio-phosphoramidate oligonucleotide inhibitor of telomerase,, Context: imetelstat, as a drug candidate for treatment of esophageal cancer. Our results  showed that imetelstat inhibited telomerase activity in a dose-dependent manner  in esophageal cancer cells. After only 1 week of imetelstat treatment, a, Context: telomerase inhibitor imetelstat in preclinical models of MRT. Three MRT cell  lines, BT-12, G401, and RT-peri, were treated with the telomerase inhibitor  imetelstat. The effects of imetelstat on telomere length, DNA damage response,, Context: BACKGROUND: Current drugs for myeloproliferative neoplasm-associated  myelofibrosis, including Janus kinase (JAK) inhibitors, do not induce complete  or partial remissions. Imetelstat is a 13-mer lipid-conjugated oligonucleotide, Context: and cell proliferation were assessed. The efficacy of imetelstat in vivo was  evaluated in subcutaneous xenografts derived from each of the cell lines.  Treatment with imetelstat resulted in inhibition of telomerase activity, marked","29122012, 22906540, 22906540, 25441685, 26332545, 25441685","Imetelstat sodium (GRN163L), is a 13-mer oligonucleotide N3'→P5' thio-phosphoramidate lipid conjugate, which represents the latest generation of telomerase inhibitors targeting the template region of the human functional telomerase RNA subunit. In preclinical trials, this compound has been found to inhibit telomerase activity in multiple cancer cell lines, as well as in vivo xenograft mouse models.","20232321, 19908230, 23727752, 20072842, 21332640, 23326372, 22906540, 23272238, 24327604, 23558965, 23545855, 23516479, 23467584, 20824134, 21062983, 21208905, 22870217, 23386830, 20048334, 22382179, 21845093, 21549308, 23521791"
What is the color of the protein Ranasmurfin?,The color of the protein Ranasmurfin is blue. This is explicitly stated in the context as the crystals of the purified and crystallized Ranasmurfin are an intense blue color.,"Context: Ranasmurfin, a previously uncharacterized approximately 13 kDa blue protein  found in the nests of the frog Polypedates leucomystax, has been purified and  crystallized. The crystals are an intense blue colour and diffract to 1.51 A, Context: Naturally occurring foam constituent and surfactant proteins with intriguing  structures and functions are now being identified from a variety of biological  sources. The ranaspumins from tropical frog foam nests comprise a range of, Context: Ranasmurfin, a previously uncharacterized approximately 13 kDa blue protein  found in the nests of the frog Polypedates leucomystax, has been purified and  crystallized. The crystals are an intense blue colour and diffract to 1.51 A, Context: proteins with a mixture of surfactant, carbohydrate binding and antimicrobial  activities that together provide a stable, biocompatible, protective foam  environment for developing eggs and embryos. Ranasmurfin, a blue protein from a, Context: blue. The proteins were identified by MALDI-TOF/TOF mass spectrometry. A total  of 22 proteins were identified, 21 of which showed differential expression with  12 proteins being upregulated and nine being downregulated. Plants responded to, Context: colour and fluorescence. The pigment presented a typical spectrum of  R-phycoerythrin, with three absorbance maxima at 499, 545 and 565 nm, and  displayed a fluorescence maximum at 578 nm. The absorbance ratio A565/A280, a","17077494, 20615601, 17077494, 20615601, 28549197, 10744320",Ranasmurfin is a blue protein.,"20615601, 17077494"
List two most common symptoms of Aagenaes syndrome.,"Yes, the context describes two main symptoms of Aagenaes syndrome. They are lymphoedema (swelling of lower extremities) and cholestasis (a form of liver disease causing jaundice).","Context: MATERIALS AND METHODS: A thorough search of internet medical databases, such as  PubMed, was carried out on known or suggested; clinical presentations,  pathogenesis, screening, causes and criteria for diagnosis of patients and their  referrals., Context: Aagenaes, who described the syndrome in 1968. The presence of lymphedema is  likely the predisposing factor for development of recurrent infections in such  patients.1 Recurrent cellulitis as such has never been described in the, Context: Aagenaes syndrome, also called Lymphedema Cholestasis Syndrome (LSC 1), is a  form of idiopathic familial intrahepatic cholestasis associated with lymphedema  of the lower extremities. It is named after the Norwegian pediatrician Oyestein, Context: literature with Aagenaes syndrome. This case highlights recurrent cellulitis as  one of the potential complications of Aagenaes syndrome., Context: We report a mother and daughter with features of Aagenaes syndrome. Unlike most  previous cases, there is no Norwegian ancestry and the pedigree favours dominant  rather than recessive inheritance., Context: BACKGROUND & AIMS: Patients with lymphoedema cholestasis syndrome 1/Aagenaes  Syndrome need a fat reduced diet when cholestatic. We wanted to assess the need  for dietary counselling outside cholestatic episodes, and hypothetized that no","23843833, 19498211, 19498211, 19498211, 9350821, 20170991","Aagenaes syndrome, also called lymphoedema cholestasis syndrome 1, is characterized by neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema, mainly affecting the lower extremities.","12712065, 11446017, 19498211, 9350821, 8278949, 24086631, 10968776, 16635916, 27614462, 25039919, 20170991, 23626552, 25317502"
What is the effect that EZH2 has on chromatin?,"No, EZH2 does not have a significant effect on chromatin decompaction. The context states that EZH2's removal through knockdown does not induce significant gene expression nor chromatin decompaction, implying that","Context: tightly correlated to the state of chromatin compaction and not to the levels of  H3K27me3-its removal through the knockdown of EZH2 does not induce significant  gene expression nor chromatin decompaction. Moreover, transcription can occur, Context: human pancreatic tumors. We used RNA interference, Western blotting, reverse  transcription-PCR, and chromatin immunoprecipitation to study the effect of EZH2  depletion on pancreatic cancer cell proliferation and survival., Context: cardiomyocytes. The results of RNA-binding protein immunoprecipitation showed  that H19 could directly bind with EZH2 in cardiomyocytes. The chromatin  immunoprecipitation assays indicated that H19 knockdown could reduce EZH2, Context: PURPOSE: Enhancer of zeste homologue 2 (EZH2), a histone methyltransferase,  plays a key role in transcriptional repression through chromatin remodeling. Our  objectives were to determine the expression pattern of EZH2 and to assess the, Context: anticancer effect of EZH2 depletion in pancreatic cancer cells. EXPERIMENTAL DESIGN: Immunohistochemistry and cytosolic/nuclear fractionation  were done to determine the expression pattern of EZH2 in normal pancreas and, Context: upregulation in multiple cancer types being associated with poor prognosis. We  investigated whether EZH2 influences the expression of RUNX3 in colorectal  cancer (CRC) and whether this is independent of methylation. We determined","24469045, 18980972, 27903964, 18980972, 18980972, 20631058",Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms,"24077602, 21892963, 22821416, 18980972, 9214638, 25680271, 20631058, 15520282, 19954516, 22966008, 24040281, 23688634, 25617436, 19026781"
What is the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD)?,"Yes, the mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD) is autosomal dominant. This means that only one copy of the altered gene in each cell is sufficient to cause","Context: Facioscapulohumeral muscular dystrophy (FSHD) is a primary muscle disorder with  autosomal dominant inheritance. FSHD was mapped to chromosome 4 locus q35, but  the gene is not yet known. It is characterised by progressive, often asymmetric,, Context: Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease,  characterized by an autosomal dominant mode of inheritance, facial involvement,  and selectivity and asymmetry of muscle involvement. In general, FSHD typically, Context: Facioscapulohumeral muscular dystrophy (FSHD) is a primary muscle disorder with  autosomal dominant inheritance. FSHD was mapped to chromosome 4 locus q35, but  the gene is not yet known. It is characterised by progressive, often asymmetric,, Context: Facioscapulohumeral muscular dystrophy (FSHD) is a primary muscle disorder with  autosomal dominant inheritance. FSHD was mapped to chromosome 4 locus q35, but  the gene is not yet known. It is characterised by progressive, often asymmetric,, Context: Facioscapulohumeral muscular dystrophy (FSHD) is a primary muscle disorder with  autosomal dominant inheritance. FSHD was mapped to chromosome 4 locus q35, but  the gene is not yet known. It is characterised by progressive, often asymmetric,, Context: Facioscapulohumeral muscular dystrophy (FSHD) is a slowly progressive myopathy  with autosomal dominant inheritance remarkable for its early involvement of  facial musculature. The purpose of our study was to assess the rate of strength","15307599, 22551571, 15307599, 15307599, 15307599, 10969520",Facioscapulohumeral muscular dystrophy has an autosomal dominant inheritance pattern.,"10864616, 10487912, 21795275, 15307599, 10969520, 23143600, 7739631, 22551571, 19248726, 22525183"
Does MicroRNA-21 (miR-21) contribute to cardiovascular disease?,"Yes, miR-21 contributes to cardiovascular disease. It is highly expressed in the cardiovascular system and its expression is deregulated under conditions such as proliferative vascular disease, cardiac hypertrophy and","Context: MicroRNA-21 (miR-21) is a highly expressed microRNA (miRNA) in cardiovascular  system. Recent studies have revealed that its expression is deregulated in heart  and vasculature under cardiovascular disease conditions such as proliferative, Context: fibroblast functions. Accordingly, miR-21 is proven to be involved in the  pathogenesis of the above-mentioned cardiovascular diseases as demonstrated by  both loss-of-function and gain-of-function approaches. Programmed cell death 4, Context: MicroRNA-21 (miR-21) is a highly expressed microRNA (miRNA) in cardiovascular  system. Recent studies have revealed that its expression is deregulated in heart  and vasculature under cardiovascular disease conditions such as proliferative, Context: microRNA-21 (miR-21, also known as Mirn21) regulates the ERK-MAP kinase  signalling pathway in cardiac fibroblasts, which has impacts on global cardiac  structure and function. miR-21 levels are increased selectively in fibroblasts, Context: vascular disease, cardiac hypertrophy and heart failure, and ischemic heart  disease. miR-21 is found to play important roles in vascular smooth muscle cell  proliferation and apoptosis, cardiac cell growth and death, and cardiac, Context: vascular disease, cardiac hypertrophy and heart failure, and ischemic heart  disease. miR-21 is found to play important roles in vascular smooth muscle cell  proliferation and apoptosis, cardiac cell growth and death, and cardiac","20560046, 20560046, 20560046, 19043405, 20560046, 20560046","MicroRNA-21 (miR-21) is a highly expressed microRNA (miRNA) in cardiovascular system. Recent studies have revealed that its expression is deregulated in heart and vasculature under cardiovascular disease conditions such as proliferative vascular disease, cardiac hypertrophy and heart failure, and ischemic heart disease. miR-21 is found to play important roles in vascular smooth muscle cell proliferation and apoptosis, cardiac cell growth and death, and cardiac fibroblast functions. Accordingly, miR-21 is proven to be involved in the pathogenesis of the above-mentioned cardiovascular diseases as demonstrated by both loss-of-function and gain-of-function approaches","19706597, 20649511, 20959496, 21464712, 19043405, 20560046, 21712654, 22882958, 22960625, 20219857, 19336275, 22038740, 23691029, 20980922, 22859901, 20015039"
Is there evidence that tomato juice lowers cholesterol levels?,"Yes, according to the context, there is evidence that tomato juice can lower cholesterol levels. The study mentioned shows that participants who consumed around 1.5 servings or less of tomato-based food products per week had significant","Context: with <1.5 servings/wk of tomato-based food products had significant but  clinically modest improvements in total cholesterol (TC) (5.38 vs. 5.51 mmol/L;  P = 0.029), the TC:HDL cholesterol ratio (4.08 vs. 4.22; P = 0.046), and, Context: liver and can inhibit the activity of the rate-limiting enzyme of cholesterol  biosynthesis, HMGCR., Context: chlorogenic acid and naringenin. Total, LDL and HDL cholesterol were  significantly lower in the intervention group after the intake of tomato juice.  In addition, a significant reduction in HMGCR activity was observed, although, Context: chlorogenic acid and naringenin. Total, LDL and HDL cholesterol were  significantly lower in the intervention group after the intake of tomato juice.  In addition, a significant reduction in HMGCR activity was observed, although, Context: chlorogenic acid and naringenin. Total, LDL and HDL cholesterol were  significantly lower in the intervention group after the intake of tomato juice.  In addition, a significant reduction in HMGCR activity was observed, although, Context: chlorogenic acid and naringenin. Total, LDL and HDL cholesterol were  significantly lower in the intervention group after the intake of tomato juice.  In addition, a significant reduction in HMGCR activity was observed, although","22223578, 24392102, 24392102, 24392102, 24392102, 24392102","Yes, there is evidence to suggest that tomato juice (and other tomato products) can decrease cholesterol concentrations. It was shown that tomatoes inhibit cholesterol biosynthesis.","24392102, 22098224, 17617941, 22223578, 21755327"
When was vaxchora first licensed by the FDA?,"Yes, the context does provide information about Vaxchora's licensing by the FDA. The exact date of licensing is not provided in the text, but it mentions that Vaxchora is ""the first vaccine approved by","Context: http://www.ncbi.nlm.nih.gov/pubmed/, http://www.clinicaltrialsregister.eu and  http://www.clinicaltrials.gov for the search terms 'vortioxetine' and 'Lu  AA21004', and by obtaining posters presented at congresses. Product labelling, Context: systemic vibriocidal antibody conversion at 6 months after a single-dose of  vaccine. Tolerability was acceptable, with the most common adverse effects  reported to be fatigue, headache, and abdominal pain., Context: Vaxchora is the first vaccine approved by the Food and Drug Administration for  the prophylaxis of cholera infection. Cholera, a potentially life-threatening  bacterial infection that occurs in the intestines and causes severe diarrhea and, Context: CONCLUSION: Vaxchora is the only FDA-approved, single-dose oral vaccine for the  prevention of cholera caused by V cholerae serogroup O1 in adult travelers from  the United States going to cholera-affected areas. Safety and efficacy has not, Context: DATA SYNTHESIS: Approval of Vaxchora, was based on efficacy of the vaccine in  human trials demonstrating 90.3% protection among those challenged with V  cholerae 10 days after vaccination and in immunogenicity studies with 90%, Context: these regions. Previous means of prophylaxis included the use of doxycycline for  the prevention of traveler's diarrhea, but doxycycline is not specific for  cholera. With the approval of Vaxchora, a live attenuated, single-dose, oral","24165478, 28622736, 29018300, 28622736, 28622736, 29018300",Vaxchora was licensed by the FDA on June 10 2016.,27425792
What is the indication for isradipine?,"Yes, the context does provide information about an indication for isradipine. The medication is used for hypertension. This is stated in the sentence: ""In order to prevent the gingival overgrowth, it is advisable to be","Context: concerning isradipine included the initial dose and its interval, subsequent  dose escalations, blood pressure response to the medication, and duration of  therapy. RESULTS: The study population comprised 12 patients, ranging in age from 10 days, Context: other dihydropyridine-derivative Ca superset 2+ antagonists do. In order to  prevent the gingival overgrowth, it is advisable to be very careful in the use  of isradipine as a therapy for hypertension and other indications., Context: isradipine exhibits minimal cardiodepressant activity and is not associated with  any negative inotropic effects. It is metabolized in the liver and dosage  adjustments may not be necessary when administered to patients with renal, Context: symptomatic medication, as well as a lower medication burden at the end of the  trial. These findings suggest that greater exposure to isradipine might slow  disease progression., Context: intravenous nicardipine before oral isradipine. Six patients received initial  therapy with oral isradipine. Isradipine was monotherapy in 7 patients and in  combination with other agents in 5 patients. The dose of isradipine required for, Context: METHODS: Pharmacy records were reviewed to identify pediatric patients who had  received isradipine. The following demographic data were obtained: age, weight,  sex, underlying medical problems, and initial blood pressure values. Information","10728516, 15257873, 7738211, 34766657, 10728516, 10728516",Isradipine is safe and effective when administered long-term in the treatment of hypertensive patients,"2137344, 11172743, 14727944, 15257873, 8963604, 12215829, 1363224, 10854683, 7848351, 9544865, 8466736, 7918132, 7955262, 10728516, 7946181, 7621840, 2949585, 8213473, 7738211, 7789292, 8205296, 2150641, 2523644, 7921533, 2523646"
Which genes are thought to be involved in medulloblastoma development?,"Yes, the PcG genes are thought to be involved in medulloblastoma development. These genes play important roles in developmental processes, including the self-renewal of hematopoietic and neural stem cells as well","Context: identification of the key tumor suppressor genes involved in medulloblastoma  development., Context: identification of the key tumor suppressor genes involved in medulloblastoma  development., Context: medulloblastoma development was described. PcG genes play an important role in  developmental processes; they are also involved in the self-renewal of  hematopoietic and neural stem cells as well as in malignant transformation., Context: medulloblastoma development was described. PcG genes play an important role in  developmental processes; they are also involved in the self-renewal of  hematopoietic and neural stem cells as well as in malignant transformation., Context: identification of the key tumor suppressor genes involved in medulloblastoma  development., Context: identification of the key tumor suppressor genes involved in medulloblastoma  development.","12384556, 12384556, 20717685, 20717685, 12384556, 12384556","Medulloblastomas are the most frequent malignant brain tumors affecting children. Disease development has been suggested to be associated with a significant number of genes, such as PTCH1, SUFU, PTEN, CREBBP, PTEN, MYT1L, NFIA, NFIB, TEAD1, TGIF2, IGF2, PCDH10, BMI1, MYC, OTX2, RASSF1A, HIC1, and CASP8.","10738305, 15705863, 21597995, 12384556, 19048113, 24252690, 14688019, 20717685"
Which phosphatase is inhibited by LB-100?,"Yes, protein phosphatase 2A (PP2A) is inhibited by LB-100. This is explicitly stated in the context information as LB-100 is described as ""a first-in-","Context: effects. Recent studies identified additional regulatory proteins, associated  with PLN, that control SR Ca-transport. These include the inhibitor-1 (I-1) of  protein phosphatase 1 (PP1), the small heat shock protein 20 (Hsp20) and the, Context: by clonogenic assay, immunofluorescence, cell cycle analysis and protein  expression were evaluated in vitro. The antitumor effects of combining LB-100  with RT were verified in vivo by using intracranial orthotopic xenograft mouse, Context: Purpose: To determine the MTD and to assess the safety, tolerability, and  potential activity of LB-100, a first-in-class small-molecule inhibitor of  protein phosphatase 2A (PP2A) in adult patients with progressive solid, Context: Purpose: To determine the MTD and to assess the safety, tolerability, and  potential activity of LB-100, a first-in-class small-molecule inhibitor of  protein phosphatase 2A (PP2A) in adult patients with progressive solid, Context: treatment has been identified. Protein phosphatase 2A (PP2A) is a ubiquitously  expressed serine/threonine phosphatase involved in cell cycle regulation and DNA  repair. Here, we examined radiosensitizing effects of LB-100, a novel inhibitor, Context: model. Pharmacologic PP2A inhibition with LB-100 prior to RT enhanced the  radiosensitivity of meningioma cells and reduced survival fraction in clonogenic  assays. LB-100 increased DNA double-strand breakage (measured by γ-H2AX),","25451386, 29199006, 28039265, 28039265, 29199006, 29199006",LB-100 is a phosphatase 2A inhibitor,29199006
What is ceritinib?,"Yes, ceritinib is an oral anaplastic lymphoma kinase (ALK) inhibitor developed by Novartis for the treatment of tumors characterized by genetic abnormalities in ALK. It has greater pre","Context: resistance to alectinib. Both ALK mutations conferred resistance to alectinib as  well as to crizotinib, but were sensitive to ceritinib and other next-generation  ALK-TKIs. Treatment of the patient with ceritinib led to a marked response., Context: mechanism in ALK-translocated lung cancer and to find the preclinical rationale  overcoming EGFR pathway-induced acquired resistance to ALK-TKIs. To this end,  ceritinib-resistant cells (H3122-CER) were established from the H3122 NSCLC cell, Context: Ceritinib is an oral anaplastic lymphoma kinase (ALK) inhibitor developed by  Novartis for the treatment of tumours characterised by genetic abnormalities in  ALK. ALK is a member of the insulin receptor family of tyrosine kinases that can, Context: Ceritinib is an oral anaplastic lymphoma kinase (ALK) inhibitor developed by  Novartis for the treatment of tumours characterised by genetic abnormalities in  ALK. ALK is a member of the insulin receptor family of tyrosine kinases that can, Context: regular approval or named patient programs, including crizotinib, ceritinib,  alectinib, brigatinib and lorlatinib. Further drugs are tested in clinical  trials. This review summarizes published data, together with drug-specific, Context: eventually become resistant, limiting its therapeutic potential. Ceritinib is an  oral second-generation ALK inhibitor with greater preclinical antitumor potency  than crizotinib in ALK-positive NSCLC. A Phase I trial of ceritinib in","25228534, 27707887, 24980964, 24980964, 30394941, 24856155","Ceritinib is a second generation tyrosine kinase inhibitor, that serves as an effective and approved oral therapy for patients with ALK-rearranged non-small cell lung cancer.","24891360, 24675041, 24980964, 26018086, 25258279, 25381900, 25101329, 25258420, 24670165, 25228534, 25733882, 25170107, 25458559"
Briefly describe a deep learning system that is more accurate than human experts at detecting melanoma.,"Yes, there are deep learning computer vision systems, specifically convolutional neural networks (CNNs) with over 50 layers, that have demonstrated superior accuracy in detecting melanoma compared to larger groups of dermatologists. These","Context: Melanoma is a fatal form of skin cancer when left undiagnosed. Computer-aided  diagnosis systems powered by convolutional neural networks (CNNs) can improve  diagnostic accuracy and save lives. CNNs have been successfully used in both, Context: existing methods employing either low-level hand-crafted features or CNNs with  shallower architectures, our substantially deeper networks (more than 50 layers)  can acquire richer and more discriminative features for more accurate, Context: BACKGROUND: Deep learning convolutional neural networks (CNN) may facilitate  melanoma detection, but data comparing a CNN's diagnostic performance to larger  groups of dermatologists are lacking., Context: BACKGROUND: Deep learning convolutional neural networks (CNN) may facilitate  melanoma detection, but data comparing a CNN's diagnostic performance to larger  groups of dermatologists are lacking., Context: BACKGROUND: Deep learning convolutional neural networks (CNN) may facilitate  melanoma detection, but data comparing a CNN's diagnostic performance to larger  groups of dermatologists are lacking., Context: provided clinical data (eg, age or lesion history/symptoms). Results obtained  using our study design cannot be extrapolated to clinical practice. CONCLUSION: Deep learning computer vision systems classified melanoma dermoscopy","29047032, 28026754, 29846502, 29846502, 29846502, 28969863","in August of 2018 a study was published where a Convolutional Neural Network's (CNN) diagnostic performance was compared with a large international group of 58 dermatologists, including 30 experts. Most dermatologists were outperformed by the CNN, the CNN had both higher sensitivity and specificity.","28026754, 29266819, 29428356, 29846502, 28969863, 29439500, 29047032"
Which method is used for prediction of novel microRNA genes in cancer-associated genomic regions?,"Yes, a computational tool called SSCprofiler is used for prediction of novel microRNA genes in cancer-associated genomic regions. It utilizes a probabilistic method based on Profile Hidden Markov Models and integrates","Context: early time of cancer progression, and global gene set enrichment analysis was  used to obtain those microRNAs significantly enriched by the change in  expression of their putative target genes. In addition, cumulative distribution, Context: computational tool (SSCprofiler) utilizing a probabilistic method based on  Profile Hidden Markov Models to predict novel miRNA precursors. Via the  simultaneous integration of biological features such as sequence, structure and, Context: cancer-associated genomic regions and rank the resulting predictions using  expression information from a full genome tiling array. Finally, four of the top  scoring predictions are verified experimentally using northern blot analysis., Context: regulating gene expression. Thus, manipulation of microRNA-transcription factor  gene networks may be provides a novel approach for developing cancer therapies., Context: mechanisms. Matching computational prediction analysis together with microarray  data seems the best method for microRNA gene target identification. MicroRNAs  together with transcription factors generate a complex combinatorial code, Context: mechanisms. Matching computational prediction analysis together with microarray  data seems the best method for microRNA gene target identification. MicroRNAs  together with transcription factors generate a complex combinatorial code","21406606, 19324892, 19324892, 19721809, 19721809, 19721809","SSCprofiler is a computational tool utilizing a probabilistic method based on Profile Hidden Markov Models to predict novel miRNA precursors. Via the simultaneous integration of biological features such as sequence, structure and conservation, SSCprofiler achieves a performance accuracy of 88.95% sensitivity and 84.16% specificity on a large set of human miRNA genes. The trained classifier is used to identify novel miRNA gene candidates located within cancer-associated genomic regions and rank the resulting predictions using expression information from a full genome tiling array. SSCprofiler is freely available as a web service at http://www.imbb.forth.gr/SSCprofiler.html.",19324892
Which drugs are included in the VAC regiment for Ewing's sarcoma?,"Yes, the VAC regimen for Ewing's sarcoma consists of three drugs: Vincristine, Actinomycin D, and Cyclophosphamide. This information is explicitly stated in the context.","Context: considered for this group of Ewing's sarcoma patients., Context: Ewing's sarcoma is the most common malignant bone tumour occurring in children  and adolescents and exists in two different clinicopathological entities:  osseous Ewing's sarcoma (OES) and extraosseous Ewing's sarcoma (EES). Five cases, Context: Vincristine, actinomycin D, and cyclophosphamide (VAC) were administered to 14  patients with Ewing's sarcoma. The primary tumors were treated with radiation  therapy and concurrent chemotherapy. Nine patients had no visible metastases at, Context: Vincristine, actinomycin D, and cyclophosphamide (VAC) were administered to 14  patients with Ewing's sarcoma. The primary tumors were treated with radiation  therapy and concurrent chemotherapy. Nine patients had no visible metastases at, Context: Vincristine, actinomycin D, and cyclophosphamide (VAC) were administered to 14  patients with Ewing's sarcoma. The primary tumors were treated with radiation  therapy and concurrent chemotherapy. Nine patients had no visible metastases at, Context: To apply safely an aggressive chemotherapy regimen like CESS 81 requires  intensive supportive care. Bleomycin is evaluated as part of the protocol for  treatment of primary Ewing's sarcoma. Bleomycin might cause pulmonary fibrosis","15613556, 11531770, 991106, 991106, 991106, 6167758","VAC regiment for Ewing's sarcoma includes vincristine, actinomycin, cyclophosphamide.","15626016, 20110048, 991106, 26271204, 9053479, 31197128, 10742059, 12441260, 7029293, 2667789, 2016622, 14521810, 15613556, 11531770, 7583389, 29541566"
What is the effect of TRH on myocardial contractility?,"Yes, TRH (Thyrotropin-releasing hormone) increases myocardial contractility. This is evident as TRH improves mean arterial pressure and enhances cardiomyocyte contractility in v","Context: which apparently was due to both a reduced TRH-induced elevation in the rate of  contraction (12.4 +/- 3.2%) and a TRH-induced decrease in relaxation rate (11.1  +/- 8.1%). Since TRH is expressed in the heart, the above findings suggest that,, Context: Thyrotropin-releasing hormone (TRH) improved mean arterial pressure (MAP) and  myocardial contractility (dp/dtmax, -dp/dtmax, Vpm, and Vmax) and increased  plasma epinephrine levels significantly at 10 min after TRH treatment in rabbits, Context: The effects of thyrotropin releasing hormone (TRH) on the contractility of  electrically stimulated and perfused isolated rat hearts were investigated. TRH  in the range of 0.1-10 mumol/l was found to exert a positive inotropic effect on, Context: The effects of thyrotropin releasing hormone (TRH) on the contractility of  electrically stimulated and perfused isolated rat hearts were investigated. TRH  in the range of 0.1-10 mumol/l was found to exert a positive inotropic effect on, Context: Thyrotropin-releasing hormone (TRH) plays an important role in central  cardiovascular regulation through the activation of different neurotransmitter  systems at distinct extrahypothalamic sites. To study possible alterations in, Context: Thyrotropin-releasing hormone (TRH) and its mRNA have been identified in the rat  heart, and TRH can enhance cardiomyocyte contractility in vivo. At present,  little is known about cardiac TRH gene transcriptional regulation in the heart.","9088928, 1611701, 9088928, 9088928, 7498977, 9225129",TRH improves myocardial contractility,"9088928, 9225129, 15096458, 2848686, 1611701, 1979356"
What is the most prominent sequence consensus for the polyadenylation site?,"Yes, there are multiple consensus sequences mentioned in the context. The most prominent one for the polyadenylation site is AAUAAA, which is referred to as the A box signal. This sequence is directly involved in cleavage and poly","Context: cleavage and polyadenylation 18 nucleotides downstream at a minor polyA site.  One match with 75% homology to the McLauchlan consensus sequence begins 17  nucleotides 3' of the second (weaker) polyA site. No matches to the Berget, Context: CA(C/T)TG, begins five nucleotides 3' of the major polyA site (used 20 times  more than the second, downstream polyA site) [Berget Nature 309, 179-182  (1984)]. The second AATAAA, located 73 nucleotides 3' of the first, directs, Context: cleavage and polyadenylation 18 nucleotides downstream at a minor polyA site.  One match with 75% homology to the McLauchlan consensus sequence begins 17  nucleotides 3' of the second (weaker) polyA site. No matches to the Berget, Context: show also a predominance of nucleotide T. This consensus sequence suggests the  importance of the immediate surroundings of the cannonical polyadenylation  signal sequence AATAAA on the efficiency of the cleavage and polyadenylation of, Context: Functional polyadenylation [poly(A)] sites consist of two sequence elements, the  AAUAAA and G/U box signals, that closely flank the site of mRNA 3'-end  formation. In agreement with previous results, random sequence insertions, Context: polyadenylation at the minor sites is controlled, at least in part, by UAUAUA,  an unusual variant of the poly(A) consensus signal approximately 25 nt upstream  of the minor polyadenylation sites. These experiments indicate that inactivation","2513486, 2513486, 2513486, 1915889, 1712333, 7901430","Functional polyadenylation [poly(A)] sites consist of two sequence elements, the AAUAAA and G/U box signals, that closely flank the site of mRNA 3'-end formation. The canonical polyadenylation signal sequence AATAAA","1993703, 6194440, 1712333, 2513486, 1915889, 7901430"
What is CPX-351,"Yes, CPX-3","Context: clinical trial. This review summarizes the clinical development of CPX-351 as  induction therapy., Context: PURPOSE: CPX-351 is a novel liposomal formulation of cytarabine and daunorubicin  which has recently been FDA approved for treatment of acute myeloid leukemia  (AML). The current study investigated the pharmacokinetics (PK) of this  liposomal formulation., Context: diagnosed high-risk/secondary acute myeloid leukemia, CPX-351 significantly  improved median overall survival versus conventional 7 + 3 chemotherapy  (cytarabine continuous infusion for 7 days plus daunorubicin for 3 days), with a, Context: diagnosed high-risk/secondary acute myeloid leukemia, CPX-351 significantly  improved median overall survival versus conventional 7 + 3 chemotherapy  (cytarabine continuous infusion for 7 days plus daunorubicin for 3 days), with a, Context: diagnosed high-risk/secondary acute myeloid leukemia, CPX-351 significantly  improved median overall survival versus conventional 7 + 3 chemotherapy  (cytarabine continuous infusion for 7 days plus daunorubicin for 3 days), with a, Context: diagnosed high-risk/secondary acute myeloid leukemia, CPX-351 significantly  improved median overall survival versus conventional 7 + 3 chemotherapy  (cytarabine continuous infusion for 7 days plus daunorubicin for 3 days), with a","29378418, 29167924, 34256819, 34256819, 34256819, 34256819","CPX-351 (United States: Vyxeos®; Europe: Vyxeos® Liposomal), a dual-drug liposomal encapsulation of daunorubicin and cytarabine in a synergistic 1:5 molar ratio, is approved by the US FDA and the EMA for the treatment of adults with newly diagnosed therapy-related acute myeloid leukemia or acute myeloid leukemia with myelodysplasia-related changes.",34256819
Is Annexin V an apoptotic marker?,"Yes, Annexin V is an apoptotic marker. It binds to phosphatidylserine on cell surfaces, which is a reliable indicator of apoptosis used in flow cytometry-based assays.","Context: rate by apoptotic marker Annexin V, and VEGF secretion level by ELISA. RESULTS: Typical apoptosis was found in NB4 cells after treatment with  quercetin. Apoptotic marker Annexin V analysis showed that the apoptotic rate of, Context: The Ca(2+)-dependent binding of Annexin V to phosphatidylserine on cell surfaces  is a reliable marker for apoptosis that is widely used in flow cytometry based  apoptosis assays. In this paper, we report a new class of Annexin V-based probes, Context: subpopulation. In this respect, we identified binding of Annexin V as an  convenient marker for apoptotic cells. Our results indicate that soluble Fc  gamma RIII in body fluids might be derived for a large part from neutrophils, Context: rate by apoptotic marker Annexin V, and VEGF secretion level by ELISA. RESULTS: Typical apoptosis was found in NB4 cells after treatment with  quercetin. Apoptotic marker Annexin V analysis showed that the apoptotic rate of, Context: RESULTS: The Annexin V flow cytometry assay distinguished among early apoptosis,  late apoptosis, and an apoptotic or necrotic phase in which the cells were  labeled with both Annexin V and PI. The comet assay detected only the latter two, Context: of apoptosis in actinomycin D-induced apoptotic Jurkat cells. Moreover, the  spontaneous apoptosis in neutrophils was shown using the new probe. The results  indicate that Rluc/Annexin V can bind to the apoptotic cells, and the signal of","16737615, 23000925, 7812008, 16737615, 12116376, 23000925","Yes, annexin V is an early apoptotic marker.","20520578, 16813956, 12573319, 16253964, 20430734, 14666384, 11585299, 21203987, 12552341, 24021657, 21340828, 25116573, 18441250, 16331047, 7812008, 27619241, 20122665, 26734508, 14676140, 11708469, 9359032, 16046522, 9462458, 26935620, 9776585, 26582221, 16737615, 9461328, 25591763, 7622868, 24412631, 22960471, 14734682, 23000925, 26112094, 16740972, 16239600, 16306419, 18554742, 20444920, 22913657, 25339644, 10541822"
Which ultraconserved element is associated with Embryonic Stem Cells (ESC) self-renewal?,"Yes, ultraconserved elements are associated with Embryonic Stem Cells (ESC) self-renewal. These DNA elements have a strong association with genes implicated in essential cell functions, such as epigenetic regulation","Context: elements clustered by sequence similarity. Furthermore, species composition and  flanking genes of clusters showed lineage-specific patterns. Ultraconserved  elements are highly enriched with binding sites to developmental transcription, Context: Mouse embryonic stem cells (ESCs) represent the naïve ground state of the  preimplantation epiblast and epiblast stem cells (EpiSCs) represent the primed  state of the postimplantation epiblast. Studies have revealed that the ESC state, Context: For self-renewal, embryonic stem cells (ESCs) require the expression of specific  transcription factors accompanied by a particular chromosome organization to  maintain a balance between pluripotency and the capacity for rapid, Context: Mouse and rat embryonic stem cell (ESC) self-renewal can be maintained by dual  inhibition of glycogen synthase kinase 3 (GSK3) and mitogen-activated protein  kinase kinase (MEK). Inhibition of GSK3 promotes ESC self-renewal by abrogating, Context: Embryonic stem (ES) cells offer insight into early developmental fate decisions,  and their controlled differentiation may yield vast regenerative potential. The  molecular determinants supporting ES cell self-renewal are incompletely, Context: these DNA elements have a strong association with genes implicated in essential  cell functions, such as epigenetic regulation, apoptosis, detoxification, innate  immunity, and sensory reception. Interestingly, we observed that ultraconserved","23217155, 23154415, 21589869, 28288968, 18283123, 23217155","Ultraconserved elements (UCEs) show the peculiar feature to retain extended perfect sequence identity among human, mouse, and rat genomes. Most of them are transcribed and represent a new family of long non-coding RNAs (lncRNAs), the transcribed UCEs (T-UCEs). Despite their involvement in human cancer, the physiological role of T-UCEs is still unknown. A lncRNA containing the uc.170+, named T-UCstem1, was identified with in vitro and in vivo evidence that it plays essential roles in embryonic stem cells (ESCs) by modulating cytoplasmic miRNA levels and preserving transcriptional dynamics.",29456181
Which key gene is involved in syndromic obesity phenotype of patients with 1p21.3 microdeletions?,"Yes, MIR137 is the key gene involved in syndromic obesity phenotype of patients with 1p21.3 microdeletions. This conclusion is derived from a case presentation of a patient carrying a novel","Context: CONCLUSIONS: This study suggests that MIR137 is the mediator of the obesity  phenotype of patients carrying 1p21.3 microdeletions., Context: BACKGROUND: Deletions in the long arm of chromosome 1 have been described in  patients with a phenotype consisting primarily of obesity, intellectual  disability and autism-spectrum disorder. The minimal region of overlap comprises, Context: CONCLUSIONS: This study suggests that MIR137 is the mediator of the obesity  phenotype of patients carrying 1p21.3 microdeletions., Context: two genes: DPYD and MIR137. CASE PRESENTATION: We describe a 10-year-old boy with syndromic obesity who  carries a novel 1p21.3 deletion overlapping the critical region with the MIR137  gene only., Context: two genes: DPYD and MIR137. CASE PRESENTATION: We describe a 10-year-old boy with syndromic obesity who  carries a novel 1p21.3 deletion overlapping the critical region with the MIR137  gene only., Context: BACKGROUND & OBJECTIVES: Microdeletion syndromes are characterized by small (<5  Mb) chromosomal deletions in which one or more genes are involved. These are  frequently associated with multiple congenital anomalies. The phenotype is the","27822311, 27822311, 27822311, 27822311, 27822311, 24056568",MIR137 is the key gene mediator of the syndromic obesity phenotype of patients with 1p21. 3 microdeletions.,"22003227, 27822311"
Which drugs are included in the Qtern pill?,"Yes, the Qtern pill contains two drugs. They are saxagliptin and dapagliflozin. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4)","Context: obtained at selected time intervals for 48 hours. A dosing schedule of 20 mg  q12h was then started and continued for seven days. Plasma samples were  collected immediately before each dose and at selected times for up to 48 hours, Context: OBJECTIVE: To review the pharmacology, pharmacokinetics, efficacy, safety, and  place in therapy of the fixed-dose combination (FDC) product, QTERN  (dapagliflozin/saxagliptin) tablets., Context: OBJECTIVES: The fixed dose combination of saxagliptin and dapagliflozin is a  recently approved antidiabetic medication. It is marketed under the brand name  Qtern. The aim of this study was to develop a simple, rapid, sensitive, and, Context: Saxagliptin/dapagliflozin fixed-dose combination tablets (Qtern®) are indicated  in the EU for the improvement of glycaemic control in adults with type 2  diabetes mellitus (T2DM), either when treatment with metformin and/or a, Context: DATA SOURCES: Searches of MEDLINE (1946 to July 1, 2017) were conducted using  the keywords QTERN, saxagliptin, and dapagliflozin. Additional data were  obtained from the prescribing information, the product dossier, and  Clinicaltrials.gov ., Context: quercetin + 1,000 mg vitamin C (QC); 1,000 mg quercetin, 1,000 mg vitamin C, 400  mg isoquercetin, 30 mg epigallocatechin gallate, and 400 mg n-3 fatty acids  (QFO); or placebo (P), taken each day for 2 wk before and during 3 d of cycling","3680580, 28884600, 32454718, 28176222, 28884600, 21813916",Qtern pill includes saxagliptin and dapagliflozin. It is indicated in the EU for the improvement of glycaemic control in adults with type 2 diabetes mellitus.,"28884600, 29176433, 32454718, 28176222"
What is included in the LACE Index?,"Yes, the LACE index includes four parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months.","Context: tools among hospitals in the United States. The LACE index is a simple tool with  4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency  visits in the previous 6 months. The authors applied logistic regression to, Context: the year before the index admission. The LACE+ index was highly discriminative  (C statistic 0.771, 95% confidence interval 0.767-0.775), was well calibrated  across most of its range of scores and had a model performance that exceeded, Context: included in the LACE index (length of stay in hospital [L], acuity of admission  [A], comorbidity [C] and emergency department utilization in the 6 months before  admission [E]), the LACE+ index incorporated patient age and sex, teaching, Context: included in the LACE index (length of stay in hospital [L], acuity of admission  [A], comorbidity [C] and emergency department utilization in the 6 months before  admission [E]), the LACE+ index incorporated patient age and sex, teaching, Context: RESULTS: The sample included admissions for craniotomy for supratentorial  neoplasm (n = 352). Assessment of the LACE+ index demonstrates a 1.02× increased  odds of 30-day readmission for every 1-unit increase in LACE+ score (P = 0.031,, Context: analyzed. All brain tumor cases for which the patient was alive at 30 days after  surgery were included (n = 352). Simple logistic regression analyses were used  to assess the ability of the LACE+ index and subsequent single variables to","29148921, 23696773, 23696773, 23696773, 30926557, 30926557","The LACE index is a simple tool that includes 4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months. It is used to predict early re-admission after hospital discharge.","29634597, 30040677, 23696773, 29343987, 30279159, 29148921, 30926557"
Does the association of PARP1 and CTCF follow a circadian rhythm?,"Yes, according to the context, the association of PARP1 and CTCF does indeed follow a circadian rhythm. This is because synchronization of the circadian rhythm by serum shock induces oscillations in PARP1-CT","Context: to the lamina. Synchronization of the circadian rhythm by serum shock induces  oscillations in PARP1-CTCF interactions, which is accompanied by oscillating  recruitment of circadian loci to the lamina, followed by the acquisition of, Context: circadian transcription. PARP1- and CTCF-regulated contacts between circadian  loci and the repressive chromatin environment at the lamina therefore mediate  circadian transcriptional plasticity., Context: circadian transcription. PARP1- and CTCF-regulated contacts between circadian  loci and the repressive chromatin environment at the lamina therefore mediate  circadian transcriptional plasticity., Context: circadian transcription. PARP1- and CTCF-regulated contacts between circadian  loci and the repressive chromatin environment at the lamina therefore mediate  circadian transcriptional plasticity., Context: circadian transcription. PARP1- and CTCF-regulated contacts between circadian  loci and the repressive chromatin environment at the lamina therefore mediate  circadian transcriptional plasticity., Context: circadian transcription. PARP1- and CTCF-regulated contacts between circadian  loci and the repressive chromatin environment at the lamina therefore mediate  circadian transcriptional plasticity.","26321255, 26321255, 26321255, 26321255, 26321255, 26321255","Synchronization of the circadian rhythm by serum shock induces oscillations in PARP1-CTCF interactions, which is accompanied by oscillating recruitment of circadian loci to the lamina, followed by the acquisition of repressive H3K9me2 marks and transcriptional attenuation. Furthermore, depletion of H3K9me2/3, inhibition of PARP activity by olaparib, or downregulation of PARP1 or CTCF expression counteracts both recruitment to the envelope and circadian transcription. PARP1- and CTCF-regulated contacts between circadian loci and the repressive chromatin environment at the lamina therefore mediate circadian transcriptional plasticity.",26321255
Are defects in recombination repair involved in carcinogenesis?,"Yes, defects in recombination repair are involved in carcinogenesis. This is because homologous recombinational repair (HRR) plays a crucial role in DNA repair, but it can also lead to deleterious","Context: We review the genes and proteins related to the homologous recombinational  repair (HRR) pathway that are implicated in cancer through either genetic  disorders that predispose to cancer through chromosome instability or the, Context: utilises ubiquitous DNA-repair proteins. Individuals with defective repair  pathways are found to be immunodeficient and many are radiosensitive. The role  of repair proteins in the development of adaptive immunity by VDJ recombination,, Context: Genomic instability is one of the hallmarks of cancer. The incidence of genetic  alterations in homologous recombination repair genes increases during cancer  progression, and 20% of prostate cancers (PCas) have defects in DNA repair, Context: cancer cases. However, recent genomic analysis has revealed that germline or  somatic inactivating mutations in BRCA1 or BRCA2, or other genes involved in the  homologous recombination (HR) pathway of DNA repair collectively occur in as, Context: Although homologous recombination (HR) is an important pathway for DNA repair,  it can also be a cause for deleterious genomic rearrangements leading to  carcinogenesis. Therefore, cells have evolved elaborate mechanisms to regulate, Context: the lesion responsible not only for the aimed cell killing of tumor cells, but  also for the general genomic instability that leads to the development of  secondary cancers among normal cells. Homologous recombination repair (HRR),","12427531, 20298636, 33044685, 27317574, 23678008, 23675572",Yes. The breast cancer-associated BRCA1 and BRCA2 proteins are strongly implicated in recombination repair.,"16258176, 12592385, 12865926, 12016139, 12427531, 12488587, 20298636, 17363343, 12191483, 23628323, 22798379, 23675572, 24104500, 17397816, 23541693, 11395777, 17636314, 21427292, 16555998, 23125219, 11178982, 24051048, 22665067, 15660524, 23620081, 21267443, 21404276, 22276468, 23721719, 10753787, 19083132"
Which are the mammalian orthologs of Drosophila Yki?,"Yes, there are mammalian orthologs of Drosophila Yki. They include salvador, merlin, LATS, and YAP1. These mammalian orthologs have similar functions to Yki in reg","Context: model for the study of the regenerative process. Here we present an overview of  the use of Drosophila for the study of regeneration and describe major recent  advances in the understanding of this process. Current studies in Drosophila, Context: vertebrates) and the Jun N-terminal kinase (JNK), which is known to promote Yki  activity in cells with disrupted polarity. Yki and JNK activity are elevated by  mutations at multiple steps in the endolysosomal pathway including mutations in, Context: ortholog of Drosophila Yorkie, a downstream component of the Hippo pathway.  Mutations in components of this pathway produce tissue overgrowth phenotypes in  the fly whereas mammalian orthologs, like salvador, merlin, LATS, and YAP1, have, Context: We have cloned a chick homologue of Drosophila dachshund (dac), termed Dach1.  Dach1 is the orthologue of mouse and human Dac/Dach (hereafter referred to as  Dach1). We show that chick Dach1 is expressed in a variety of sites during, Context: comprehensive comparative analysis of Drosophila HP1 homologs. HP1  differentially homodimerizes and heterodimerizes in vivo and in vitro HP1b and  HP1c, but not HP1a, are localized to both the nucleus and cytoplasm. The, Context: apicobasal polarity, adhesion and tissue architecture. As vertebrate homologs of  some Drosophila nTSGs are linked to tumor formation, identifying molecular  changes in signaling associated with nTSG loss could inform understanding of","21338344, 22101275, 17980593, 11804780, 30659116, 22101275",There are two mammalian orthologs of Yki: YAP and TAZ,"22898666, 17980593, 18413746, 23484853, 23985272, 19878874, 22101275"
What is the function of Taraxasterol  in rheumatoid arthritis?,"Yes, taraxasterol has an anti-inflammatory effect in rheumatoid arthritis. It reduces nitric oxide, prostaglandin E2 and cyclooxygenase-2 levels, which","Context: protective effect of taraxasterol against rheumatoid arthritis is mediated via  the modulation of inflammatory responses in mice., Context: arthritis model mice. Taraxasterol treatment also significantly reduced nitric  oxide, prostaglandin E2 and cyclooxygenase-2 levels compared with those in the  rheumatoid arthritis model group. These observations indicate that the, Context: protective effect of taraxasterol against rheumatoid arthritis is mediated via  the modulation of inflammatory responses in mice., Context: Taraxasterol is an effective component of dandelion that has anti-inflammatory  effects in vivo and in vitro. The present study was performed to explore whether  taraxasterol exhibits a protective effect against rheumatoid arthritis through, Context: Taraxasterol is an effective component of dandelion that has anti-inflammatory  effects in vivo and in vitro. The present study was performed to explore whether  taraxasterol exhibits a protective effect against rheumatoid arthritis through, Context: arthritis model mice. Taraxasterol treatment also significantly reduced nitric  oxide, prostaglandin E2 and cyclooxygenase-2 levels compared with those in the  rheumatoid arthritis model group. These observations indicate that the","28101182, 28101182, 28101182, 28101182, 28101182, 28101182",Taraxasterol suppresses inflammation in rheumatoid arthritis.,"28101182, 27109342"
What is the drug  gantenerumab targeting?,"Yes, gantenerumab targets beta-amyloid plaques. It's an investigational fully human anti-amyloid beta monoclonal antibody with a high capacity to bind and remove beta-amyloid","Context: possible disease-modifying effects. Gantenerumab is an investigational fully  human anti-amyloid beta monoclonal antibody with a high capacity to bind and  remove beta-amyloid plaques in the brain. This compound, currently undergoing, Context: β-amyloid (Aβ) peptide and tau protein, the principal neurophatological  hallmarks of the disease. Areas covered: Phase III clinical studies of emerging  anti-Aβ drugs for the treatment of AD were searched in US and EU clinical trial, Context: BACKGROUND: Gantenerumab is a fully human anti-Aβ monoclonal antibody in  clinical development for the treatment of Alzheimer disease (AD). OBJECTIVES: To investigate whether treatment with gantenerumab leads to a, Context: possible disease-modifying effects. Gantenerumab is an investigational fully  human anti-amyloid beta monoclonal antibody with a high capacity to bind and  remove beta-amyloid plaques in the brain. This compound, currently undergoing, Context: possible disease-modifying effects. Gantenerumab is an investigational fully  human anti-amyloid beta monoclonal antibody with a high capacity to bind and  remove beta-amyloid plaques in the brain. This compound, currently undergoing, Context: Previous findings from the positron emission tomography (PET) substudy of the  SCarlet RoAD and Marguerite RoAD open-label extension (OLE) showed gantenerumab  doses up to 1200 mg every 4 weeks administered subcutaneously resulted in robust","24255592, 27678025, 21987394, 24255592, 24255592, 33336218","Gantenerumab significantly reduced amyloid plaques, cerebrospinal fluid total tau, and phospho-tau181 and attenuated increases of neurofilament light chain.","33336218, 34155411, 34198582"
List proteins with HEAT repeats,"Yes, based on the context, there are two types of proteins that have HEAT repeats mentioned - alpha-Kaps (which fall into two groups, alpha1 and alpha2) and beta-Kaps. The text also mentions","Context: complexities. Five popular database search engines Mascot, X!Tandem, MS-GF+ and  combinations thereof were evaluated for every protein inference tool. In total  >186 proteins lists were analyzed and carefully compare using three metrics for, Context: repeats. The number and order of these repeats have not changed since the common  origin of fungi, plants, and mammals. Phylogenetic analysis suggests that the  various alpha-Kaps fall into two groups, alpha1 and alpha2. Whereas animals, Context: that the alpha-Kaps and beta-Kaps (and for that matter, all Arm and HEAT  repeat-containing proteins) are members of the same protein superfamily.  Phylogenetic analysis indicates that there are at least three major groups of, Context: determined to 2.4 A resolution with single-wavelength anomalous dispersion  phasing methods. The structure exhibits five canonical HEAT repeats along with  an extended 31-amino-acid loop (loop 8) between the fourth and fifth repeat that, Context: encode both types, the yeast genome encodes only an alpha1-Kap. The beta-Kaps  are characterized by 14-15 tandemly arranged HEAT motifs. We show that the Arm  repeats of alpha-Kaps and the HEAT motifs of beta-Kaps are similar, suggesting, Context: surface for potential protein-protein interactions. HEAT domains are often  employed for such macromolecular contacts. The Symplekin HEAT region not only  structurally aligns with several established scaffolding proteins, but also has","27498275, 9391096, 9391096, 19576221, 9391096, 19576221","mTOR, TOG5,  DNA-PKcs, HEATR1, Rif1, B56γ, PR65/A, SF3b155, Pds5B","27072897, 26676747, 27549742, 28512144, 27066066, 20007090, 28415797, 28668119, 24120762, 22315229"
What is protein palmitoylation?,"Yes, protein palmitoylation is the reversible attachment of a fatty acid, typically C16 palmitate, to intracellular cysteine residues of proteins via a thioester linkage. This modification","Context: Palmitoylation (S-acylation) is the reversible conjugation of a fatty acid  (usually C16 palmitate) to intracellular cysteine residues of proteins via a  thioester linkage. Palmitoylation anchors intracellular regions of proteins to, Context: membranes because the palmitoylated cysteine is recruited to the lipid bilayer.  NCX1 is palmitoylated at a single cysteine in its large regulatory intracellular  loop. The presence of an amphipathic α-helix immediately adjacent to the NCX1, Context: The RESID Database of Protein Modifications is a comprehensive collection of  annotations and structures for protein modifications and cross-links including  pre-, co-, and post-translational modifications. The database provides:, Context: proteins and post-translational modifications., Context: regulated by this important protein modification., Context: Protein N-terminal acetylation is one of the most common modifications occurring  co- and post-translationally on either eukaryote or prokaryote proteins.  However, compared to other protein modifications, the physiological role of","31935590, 31935590, 15174122, 20469934, 29327913, 23745983","Protein S-palmitoylation, the covalent lipid modification of the side chain of Cys residues with the 16‑carbon fatty acid palmitate, is the most common acylation, and it enhances the membrane stability of ion channels. This post-translational modification (PTM) determines a functional mechanism of ion channel life cycle from maturation and membrane trafficking to localization.","29189096, 32003970, 31935590, 31812495"
Does lucatumumab bind to CD140?,"No, lucatumumab does not bind to CD140. According to the context, lucatumumab is a fully humanized anti-CD40 antibody that blocks interaction of CD40L with CD40","Context: h following the first infusion, and 124 h following the fourth infusion. In  summary, lucatumumab had acceptable tolerability, pharmacokinetics that  supported chronic dosing and pharmacodynamic target antagonism at doses of 3.0, Context: In this open-label, multicentre, phase 1 study a fully human anti-CD40  antagonist monoclonal antibody, lucatumumab, was evaluated in patients with  relapsed/refractory multiple myeloma (MM). The primary objective was to, Context: Lucatumumab is a fully humanized anti-CD40 antibody that blocks interaction of  CD40L with CD40 and also mediates antibody-dependent cell-mediated cytotoxicity  (ADCC). We evaluated lucatumumab in a phase I clinical trial in chronic, Context: Lucatumumab is a fully humanized anti-CD40 antibody that blocks interaction of  CD40L with CD40 and also mediates antibody-dependent cell-mediated cytotoxicity  (ADCC). We evaluated lucatumumab in a phase I clinical trial in chronic, Context: Lucatumumab is a fully humanized anti-CD40 antibody that blocks interaction of  CD40L with CD40 and also mediates antibody-dependent cell-mediated cytotoxicity  (ADCC). We evaluated lucatumumab in a phase I clinical trial in chronic, Context: response for 230 days. Saturation of CD40 receptor on CLL cells was uniform at  all doses post-treatment but also persisted at trough time points in the 3.0  mg/kg or greater cohorts. At the MTD, the median half-life of lucatumumab was 50","22475052, 22861192, 22475052, 22475052, 22475052, 22475052","No, lucatumumab is a fully humanized anti-CD40 antibody that blocks interaction of CD40L with CD40 and also mediates antibody-dependent cell-mediated cytotoxicity (ADCC).",22475052
What eye disease(s) are associated with ocular toxoplasmosis?,"Yes, retinal detachment is associated with ocular toxoplasmosis. This is based on the context given, where it mentions that the purpose of the study was to assess the frequency of retinal detachment (RD) and","Context: also analyzed. RESULTS: Thirty-five eyes of 28 patients with ocular toxoplasmosis and  sufficient follow-up were studied. Median age of patients was 40 years (range,  7-93 years). Median follow-up time was 22.5 months (range, 6-96 months). Four of, Context: PURPOSE: To assess the frequency of retinal detachment (RD) and associated  clinical features in ocular toxoplasmosis. METHODS: A review of the medical records of patients diagnosed with ocular, Context: BACKGROUND: Retinochoroiditis is the most common ocular manifestation of  congenital toxoplasmosis, but other associated ophthalmological pathologies can  also occur. The aim of this study was to determine the nature of the latter in, Context: linked to human lesions in the eye. An experimental model for congenital ocular  toxoplasmosis was developed in C57BL/6 mice with the purpose to evaluate  Toxoplasma induced ocular pathology during fetal life. Toxoplasma gondii, ME-49, Context: treatments were reviewed. Main outcome measures were the rate of RD in ocular  toxoplasmosis, degree of vision loss, and final anatomical status of the retina.  Disease- and treatment-related factors associated with poor visual outcome were, Context: treatments were reviewed. Main outcome measures were the rate of RD in ocular  toxoplasmosis, degree of vision loss, and final anatomical status of the retina.  Disease- and treatment-related factors associated with poor visual outcome were","25127047, 25127047, 15906073, 17596951, 25127047, 25127047",Retinochoroiditis is the most frequent manifestation of congenital toxoplasmosis Infectious uveitis accounted for 37% of posterior uveitis cases of which toxoplasmosis was the most common cause. Toxoplasmosis was the most common cause of posterior uveitis (60%),"30332547, 25127047, 33060522, 31589483, 31429610, 32068467, 17596951, 15906073"
What is known about the effect of acupuncture in smoking cessation ?,"Yes, according to the context, acupuncture combined with auricular point sticking and pressing has a reliable therapeutic effect for smoking cessation. In a study of 141 adults, those who received acupuncture alone","Context: BACKGROUND: Tobacco smoking is responsible for human diseases of the lung,  heart, circulatory system and various kinds of cancers, and is a serious public  health problem worldwide. Acupuncture has been promoted as a treatment modality, Context: The use of alternative medicine for smoking cessation have been increasing  steadily in recent years. A series of clinical group studies was performed to  clarify the effect, outcome and success rate of an acupuncture treatment for, Context: RESULTS: Thirty-six were cured, 12 cases were effective, 5 cases were  ineffective. CONCLUSION: Acupuncture combined with auricular point sticking and pressing has  reliable therapeutic effect for smoking cessation, but it is needed that the, Context: OBJECTIVES: This study examined the effect of acupuncture alone and in  combination with education on smoking cessation and cigarette consumption. METHODS: We prospectively studied 141 adults in a quasi-factorial design using, Context: for smoking cessation. However, its efficacy still remains controversial. METHODS: We conducted a prospective, randomized, controlled trial using  auricular acupuncture for smoking cessation in 131 adults who wanted to stop, Context: for smoking cessation. However, its efficacy still remains controversial. METHODS: We conducted a prospective, randomized, controlled trial using  auricular acupuncture for smoking cessation in 131 adults who wanted to stop","17698433, 15861492, 18405159, 12356614, 17698433, 17698433","Ear acupressure (EAP) and ear acupuncture have been used for smoking cessation, and some positive results have been reported. Auricular (ear) acupressure has been purported to be beneficial in achieving smoking cessation in some studies, while in others has been deemed insignificant. The combined acupuncture-education group showing the greatest effect from treatment.","17264832, 17698433, 10024707, 12356614, 18405159, 12416359, 22373002, 11154059, 16566674, 24030452, 15861492, 15004442"
List 3 indications for Bupropion,"Yes, the context mentions three indications for bupropion. They are: 1. Psychostimulant drug abuse 2. Attention-deficit hyperactivity disorder (ADHD) 3. Obesity","Context: were conducted from June 2003 through August 2004. No time limit was specified  in the searches, which were conducted using the search terms bupropion,  bupropion SR, and bupropion XL., Context: listing on the PBS, while the utilisation of NRTs appears to have increased,  despite the price differential in favour of bupropion. IMPLICATIONS: Given the greater interest among smokers in NRT than bupropion, Context: bupropion is being tested as a candidate treatment for psychostimulant drug  abuse, attention-deficit hyperactivity disorder (ADHD) and obesity. Bupropion is  available in three bioequivalent oral formulations, immediate release (IR),, Context: bupropion is being tested as a candidate treatment for psychostimulant drug  abuse, attention-deficit hyperactivity disorder (ADHD) and obesity. Bupropion is  available in three bioequivalent oral formulations, immediate release (IR),, Context: bupropion is being tested as a candidate treatment for psychostimulant drug  abuse, attention-deficit hyperactivity disorder (ADHD) and obesity. Bupropion is  available in three bioequivalent oral formulations, immediate release (IR),, Context: bupropion is being tested as a candidate treatment for psychostimulant drug  abuse, attention-deficit hyperactivity disorder (ADHD) and obesity. Bupropion is  available in three bioequivalent oral formulations, immediate release (IR),","16027765, 18264876, 17227286, 17227286, 17227286, 17227286","Bupropion is used to treat Obesity, for smoking cessation and for depression","16831112, 15479310, 9554323, 17227286, 12043548, 18219560, 18264876, 26137782, 18619194, 15155135, 10804045, 27038550, 16546007, 25223901, 25661549, 25895022, 23859696, 21142259, 16027765, 21274361"
List the neurotransmitters that are metabolized by MAOA.,"Yes, according to the context, dopamine and serotonin are two neurotransmitters metabolized by MAOA.","Context: motor impulsiveness in BPD. Additionally, BPD subjects reported higher BIS-11  attentional impulsiveness versus ASPD participants (t(1,36)=2.3, p=0.025). CONCLUSION: These preliminary results suggest that MAOA-L may modulate the, Context: OBJECTIVE: Monoamine oxidase-A (MAO-A) is a key mitochondrial enzyme that  metabolizes biogenic amine neurotransmitters such as dopamine and serotonin.  Individuals with atypical depression (AD) are particularly responsive to, Context: OBJECTIVE: Monoamine oxidase-A (MAO-A) is a key mitochondrial enzyme that  metabolizes biogenic amine neurotransmitters such as dopamine and serotonin.  Individuals with atypical depression (AD) are particularly responsive to, Context: OBJECTIVE: Monoamine oxidase-A (MAO-A) is a key mitochondrial enzyme that  metabolizes biogenic amine neurotransmitters such as dopamine and serotonin.  Individuals with atypical depression (AD) are particularly responsive to, Context: OBJECTIVE: Monoamine oxidase-A (MAO-A) is a key mitochondrial enzyme that  metabolizes biogenic amine neurotransmitters such as dopamine and serotonin.  Individuals with atypical depression (AD) are particularly responsive to, Context: Monoamine oxidase A (MAOA) catalyzes monoamine neurotransmitters including  dopamine, 5-hydroxytryptamine (5-HT, serotonin), and norepinephrine. MAOA also  plays a key role in emotional regulation. The aim of this study was to","29073746, 19214141, 19214141, 19214141, 19214141, 24510409","The monoamine oxidase-A (MAOA) gene plays a vital role in the metabolism of neurotransmitters, e.g, serotonin, norepinephrine, and dopamine.","23761378, 24510409, 19456107, 25733484, 21554924, 20485326, 18227761, 24865426, 20204405, 24652311, 19368859, 19214141"
Summarize the cause of autosomal dominant Spinocerebellar Ataxia type 3.,"Yes, the cause of autosomal dominant Spinocerebellar Ataxia type 3 (SCA3) is an abnormal CAG repeat expansion in the exon 10 of the ATXN3 gene.","Context: AIMS: Spinocerebellar ataxia type 3 (SCA3) is an inherited spinocerebellar  ataxia caused by the expansion of trinucleotide CAG repeats in the gene encoding  ataxin-3. The clinical manifestations of SCA3 include peripheral neuropathy,, Context: expansions of an unstable CAG repeat localized in the coding region of the  causative genes. Another related disease, dentatorubropallidoluysian atrophy  (DRPLA) is also caused by an unstable triplet repeat and can present as SCA in, Context: Spinocerebellar ataxia type 1 and type 3 (SCA1, SCA3) are autosomal dominant  neurodegenerative disorders caused by expanded CAG trinucleotide repeats in  novel genes. In our collective of SCA1 and SCA3 families, we observed distortion, Context: Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is a progressive  autosomal dominant neurodegenerative disease caused by abnormal CAG repeats in  the exon 10 of ATXN3. The accumulation of the mutant ataxin-3 proteins carrying, Context: Spinocerebellar ataxia type 1 (SCA1), spinocerebellar ataxia type 2 (SCA2) and  Machado-Joseph disease or spinocerebellar ataxia type 3 (MJD/SCA3) are three  distinctive forms of autosomal dominant spinocerebellar ataxia (SCA) caused by, Context: Spinocerebellar ataxia type 1 (SCA1), spinocerebellar ataxia type 2 (SCA2) and  Machado-Joseph disease or spinocerebellar ataxia type 3 (MJD/SCA3) are three  distinctive forms of autosomal dominant spinocerebellar ataxia (SCA) caused by","23617879, 9629399, 9048937, 34535635, 9629399, 9629399",Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is a progressive autosomal dominant neurodegenerative disease caused by abnormal CAG repeats in the exon 10 of ATXN3.,"33219521, 9048937, 32266540, 32346735, 34535635, 26123252, 34159894, 9629399, 34565721, 15316156, 31639609"
Are retroviruses used for gene therapy?,"Yes, according to the context, recombinant retroviruses are used for gene therapy in treating both inherited and acquired diseases involving hematopoietic cells. However, their therapeutic application has been limited by problems of vector","Context: The therapeutic application of recombinant retroviruses and other integrating  gene transfer vectors has been limited by problems of vector expression and  vector-mediated genotoxicity. These problems arise in large part from the, Context: Mobile genetic elements with the ability to integrate genetic information into  chromosomes can cause disease over short periods of time and shape genomes over  eons. These elements can be used for functional genomics, gene transfer and, Context: The therapeutic application of recombinant retroviruses and other integrating  gene transfer vectors has been limited by problems of vector expression and  vector-mediated genotoxicity. These problems arise in large part from the, Context: The therapeutic application of recombinant retroviruses and other integrating  gene transfer vectors has been limited by problems of vector expression and  vector-mediated genotoxicity. These problems arise in large part from the, Context: Retrovirus-mediated gene transfer into hematopoietic cells may provide a means  of treating both inherited and acquired diseases involving hematopoietic cells.  Implementation of this approach for disorders resulting from mutations affecting, Context: Retrovirus-mediated gene transfer into hematopoietic cells may provide a means  of treating both inherited and acquired diseases involving hematopoietic cells.  Implementation of this approach for disorders resulting from mutations affecting","21247248, 16717285, 21247248, 21247248, 7624311, 7624311","Gene therapy is one of the most promising and active fields in therapeutic research. Gene therapy is a treatment option that introduces genetic material in vivo or ex vivo into the cells of an affected organism in order to: exchange a defective gene; manipulate a disease-related gene; or introduce an additional gene copy for overexpression of the encoded protein to generate a curative biological effect. Somatic gene therapy is gene transfer by a specific vector to a somatic cell; in contrast to germline gene therapy, the modification of the cell is restricted to the recipient and cannot be passed to her/his progeny. High efficiency of gene transfer, high specificity for the target cells, long-lasting expression of the transgene and safety without adverse reactions are the desired characteristics of an ideal vector for gene transfer. Retroviral (gretroviral and lentiviral) vectors have now been used in more than 350 gene-therapy studies. Retroviral vectors are particularly suited for gene-correction of cells due to long-term and stable expression of the transferred transgene(s), and also because little effort is required for their cloning and production. Several monogenic inherited diseases, mostly immunodeficiencies, can now be successfully treated.","24120896, 16251873, 12686720, 23921576, 15912200, 23843498, 23884859, 19435468, 23845071, 23860311, 23845947, 23845948, 21943326"
What is Dysphoric Milk Ejection Reflex?,"Yes, Dysphoric Milk Ejection Reflex (D-MER) is a condition where an abrupt dysphoria or negative emotion occurs just before or during the letdown reflex and continues for a short period, typically no more","Context: BACKGROUND: Dysphoric milk ejection reflex (D-MER) is characterized by an abrupt  dysphoria, or undesirable feeling that occurs with the MER and continues for no  more than a few minutes. After milk ejection, the dysphoria vanishes., Context: Dysphoric milk ejection reflex (D-MER) results in waves of negative emotions  that last from shortly before initial milk ejection until baby starts to feed  vigorously Symptoms may decrease by 3 months or they may continue throughout the, Context: BACKGROUND: Dysphoric milk ejection reflex (D-MER) is characterized by an abrupt  dysphoria, or undesirable feeling that occurs with the MER and continues for no  more than a few minutes. After milk ejection, the dysphoria vanishes., Context: BACKGROUND: Dysphoric milk ejection reflex (D-MER) is characterized by an abrupt  dysphoria, or undesirable feeling that occurs with the MER and continues for no  more than a few minutes. After milk ejection, the dysphoria vanishes., Context: BACKGROUND: Dysphoric milk ejection reflex (D-MER) is characterized by an abrupt  dysphoria, or undesirable feeling that occurs with the MER and continues for no  more than a few minutes. After milk ejection, the dysphoria vanishes., Context: BACKGROUND: Dysphoric milk ejection reflex (D-MER) is characterized by an abrupt  dysphoria, or undesirable feeling that occurs with the MER and continues for no  more than a few minutes. After milk ejection, the dysphoria vanishes.","29115857, 20443435, 29115857, 29115857, 29115857, 29115857","Dysphoric milk ejection reflex (D-MER) is characterized by an abrupt dysphoria, or undesirable feeling that occurs with the MER and continues for no more than a few minutes. After milk ejection, the dysphoria vanishes. Symptoms may decrease by 3 months or they may continue throughout the breastfeeding period.","29115857, 20443435, 21645333"
Are tumour specific antigens originating from known protein coding genes?,"Yes, according to the context, tumour specific antigens can originate from known protein coding genes. This is because tumour-associated differentiation antigens, which are a type of tumour specific antigen, are derived from","Context: indirect evidence is still missing. It is thus unknown how many tumours express  tumour specific antigen at all and whether these putative antigens are of unique  specificity or are shared by certain groups of (histologically related), Context: Early investigations into the immune surveillance of chemically-induced sarcomas  led to two important concepts in tumour immunobiology: one, tumour rejection can  be elicited by immune recognition of tumour antigens; and two, tumours express, Context: existence of tumour antigen can be deduced from the existence of tumour specific  cytotoxic T cells isolated from TIL. However, for other epidemiologically more  important tumours such as carcinomas of the colon, breast and lung, even, Context: unique sets of antigens, which are known as tumour-specific antigens. The  pioneering studies of Srivastava and colleagues led to the proposal that  heat-shock proteins (HSPs) function as ubiquitous tumour-specific antigens, with, Context: Tumour-derived peptides eluted from MHC molecules of tumour tissue are also a  promising source of antigen. Tumour antigens are mostly of weak immunogenicity,  because the vast majority are tumour-associated differentiation antigens already, Context: Tumour-derived peptides eluted from MHC molecules of tumour tissue are also a  promising source of antigen. Tumour antigens are mostly of weak immunogenicity,  because the vast majority are tumour-associated differentiation antigens already","1423320, 12766764, 1423320, 12766764, 11599633, 11599633","Heat-shock proteins (HSPs) function as ubiquitous tumour-specific antigens, with the specificity residing in a population of bound peptides that identify the tissue of origin of the HSP. Tumour antigens are mostly of weak immunogenicity, because the vast majority are tumour-associated differentiation antigens already 'seen' by the patient's immune system.","7517178, 12766764, 21388431, 11599633, 1423320, 23561850, 18031135"
Which gene is primarily associated with the Saethre-Chotzen syndrome?,"Yes, the TWIST gene is primarily associated with the Saethre-Chotzen syndrome. This gene, located on chromosome 7p21.2, encodes a transcription factor that contains DNA binding and helix","Context: clinical diagnosis of Saethre-Chotzen syndrome. METHODS: Patients with a clinical diagnosis as well as those with a genetic  diagnosis of Saethre-Chotzen syndrome (n = 34) were included in the study., Context: transcription factor with DNA binding and helix-loop-helix domains. Numerous  missense and nonsense mutations cluster in the functional domains, without any  apparent mutational hot spot. Two novel point mutations and one novel, Context: study whether a proportion of these families might have mutations in  Saethre-Chotzen-associated genes. DNA sequence analysis of TWIST1 showed no  pathogenic mutations in the coding sequence in any of the 26 patients. MLPA, Context: Saethre-Chotzen syndrome is caused by mutations in the TWIST gene on chromosome  7p21.2. However, Muenke et al. [(1997); Am J Hum Genet 91: 555-564] described a  new subgroup carrying the Pro250Arg mutation in the fibroblast growth factor, Context: phenotype of Saethre-Chotzen syndrome. Array CGH also showed deletion of four  other genes at 7p21.1 (SNX13, PRPS1L1, HD9C9, and FERD3L) and the deletion of  six genes (CACNA2D2, C3orf18, HEMK1, CISH, MAPKAPK3, and DOCK3) at 3p21.31. Our, Context: Saethre-Chotzen syndrome is a relatively common craniosynostosis disorder with  autosomal dominant inheritance. Mutations in the TWIST gene have been identified  in patients with Saethre-Chotzen syndrome. The TWIST gene product is a","15923834, 10649491, 19863427, 17036334, 22628249, 10649491","Saethre-Chotzen syndrome is a craniosynostosis syndrome that is rarely diagnosed prenatally . It is caused by cytogenetic deletions or mutations of the TWIST1 gene . Of the 37 patients with classic features of the syndrome, the overall detection rate for TWIST mutations was 68% . Increased risk for developmental delay is associated with TWIST deletions .","19863427, 8988166, 20125191, 8988167, 19860490, 21811467, 12221714, 10649491, 11314068, 16502419, 9259286, 11772178, 29663378, 22628249, 19952666, 12116251, 22569119, 21814570, 15880747, 25118508, 30040876, 16251895, 17868088, 19483581, 9215678, 24585549, 14513358, 28521820, 15735646, 17437280, 10094188, 11248247, 15923834, 28220539"
Which R/bioconductor have been developed for copy number analysis?,"Yes, several R/Bioconductor packages have been developed for copy number analysis. These include copynumber, SomatiCA, CNVRanger, and others that are specifically designed to facilitate access for both manual and automated methods of","Context: algorithms, due to the emergence of very high density scans of copy number. RESULTS: A comprehensive Bioconductor package for copy number analysis is  presented. The package offers a unified framework for single sample,, Context: computationally highly efficient algorithm is proposed that utilizes  vector-based operations in R. Three case studies are presented. CONCLUSIONS: The R package copynumber is a software suite for segmentation of, Context: change in each somatic copy number aberration (SCNA), and 4) a list of  substantial genomic aberration events including gain, loss and LOH. SomatiCA is  available as a Bioconductor R package at, Context: detection and computational inference of CNVs from SNP array and next-generation  sequencing data are available. We present the CNVRanger R/Bioconductor package  which implements a comprehensive toolbox for structured downstream analysis of, Context: package, a new R tool package and a new R/Bioconductor data package to  facilitate access for both manual and automated methods., Context: allele-specific estimates of copy number. This paper illustrates a workflow for  the estimation of allele-specific copy number and integration of the  marker-level estimates with complimentary Bioconductor software for inferring","23442169, 23442169, 24265680, 31392308, 24194598, 22523482","CNVRanger, seqCNA, iGC, PLRS, SomatiCA, Copynumber, crlmm, KC-SMARTR are all R/bioconductor packages for copy number analysis","21070656, 28088185, 24597965, 23419375, 24265680, 31392308, 23442169, 22523482"
What are the CADD scores?,"Yes, CADD scores are a measure of the deleterious effect of human single nucleotide variants and short insertions and deletions anywhere in the reference assembly. They are calculated using a machine learning model that integrates more than","Context: American Heart Association recommendation of a score of more than 2. RESULTS: We enrolled 2056 patients (mean age 68.0 yr, 1046 (50.9%) women) who  had a rate of stroke of 1.8% at 7 days and 3.2% at 90 days. An ABCD2 score of, Context: Interface and improved mechanisms for integrating CADD scores into other tools  or applications. CADD scores, software and documentation are available at  https://cadd.gs.washington.edu., Context: InSiGHT's Variant Interpretation Committee. Overall, we found CADD scores do  predict pathogenicity (Spearman's ρ = 0.595, P < 0.001). However, we discovered  31 major discrepancies between the InSiGHT classification and the CADD scores;, Context: disorders. CADD is an integrative annotation built from more than 60 genomic  features, and can score human single nucleotide variants and short insertion and  deletions anywhere in the reference assembly. CADD uses a machine learning model, Context: disorders. CADD is an integrative annotation built from more than 60 genomic  features, and can score human single nucleotide variants and short insertion and  deletions anywhere in the reference assembly. CADD uses a machine learning model, Context: common in our patient population, and the null distribution of all possible  SNVs. RESULTS: The median CADD scores of intronic and nonsynonymous variants were  significantly different between rare and common SNVs (P < 0.0001). Despite these","21646462, 30371827, 25871441, 30371827, 30371827, 27148939","Combined Annotation-Dependent Depletion (CADD) is a widely used measure of variant deleteriousness that can effectively prioritize causal variants in genetic analyses, particularly highly penetrant contributors to severe Mendelian disorders. CADD is an integrative annotation built from more than 60 genomic features, and can score human single nucleotide variants and short insertion and deletions anywhere in the reference assembly.","25871441, 30371827, 27148939, 29340599"
Describe the mechanism of action of Lisocabtagene maraleucel.,"No, the context does not provide explicit details about the mechanism of action of Lisocabtagene maraleucel. The context mentions this CAR T-cell product along with tisagenlecleucel, but it only describes","Context: monoclonal antibody targeting trophoblastic cell-surface antigen 2 (Trop-2).  Trop-2 is highly expressed on the surface of TNBC cells, making it an attractive  target. Areas covered We explore the mechanism, pharmacology, efficacy, safety,, Context: selection for the management of patients with relapsed/refractory aggressive  B-cell lymphomas., Context: tisagenlecleucel, and lisocabtagene maraleucel. These products differ in  construct, manufacturing, clinical trial design and toxicity profile. Patient  selection for CAR T-cells, and the ideal product for a given patient, involves, Context: tisagenlecleucel, and lisocabtagene maraleucel. These products differ in  construct, manufacturing, clinical trial design and toxicity profile. Patient  selection for CAR T-cells, and the ideal product for a given patient, involves, Context: tisagenlecleucel, and lisocabtagene maraleucel. These products differ in  construct, manufacturing, clinical trial design and toxicity profile. Patient  selection for CAR T-cells, and the ideal product for a given patient, involves, Context: tisagenlecleucel, and lisocabtagene maraleucel. These products differ in  construct, manufacturing, clinical trial design and toxicity profile. Patient  selection for CAR T-cells, and the ideal product for a given patient, involves","34651524, 32611216, 32611216, 32611216, 32611216, 32611216","Lisocabtagene maraleucel is an autologous, CD19-directed, chimeric antigen receptor (CAR) T-cell product.","31099671, 32611216, 32670869, 31899702, 32888407, 31677848, 31648957, 32740094"
Does surgery for ovarian endometriomas improve fertility?,"Yes, according to a retrospective study, conservative surgery on ovarian endometriomas can potentially improve fertility outcomes. The study showed that 60% of women achieved a term pregnancy after laparoscopic endometri","Context: OBJECTIVE: To investigate whether conservative surgery on ovarian endometriomas  before an IVF cycle improves fertility outcomes. DESIGN: Retrospective, matched case-control study. SETTING: Two academic IVF programs., Context: complications of laparoscopic surgery. Conversely, conservative surgical  treatment of ovarian endometriomas in symptomatic women does not impair IVF or  intracytoplasmic sperm injection success rates., Context: controlled study that compares the effects of surgical removal versus expectant  management of endometrioma on ovarian performance and pregnancy outcomes in  women undergoing IVF is warranted., Context: controlled study that compares the effects of surgical removal versus expectant  management of endometrioma on ovarian performance and pregnancy outcomes in  women undergoing IVF is warranted., Context: controlled study that compares the effects of surgical removal versus expectant  management of endometrioma on ovarian performance and pregnancy outcomes in  women undergoing IVF is warranted., Context: outcome, have been promising: 12 of 20 women (60%) achieved a term pregnancy  following a laparoscopic endometrioma procedure alone. Of the eight women with  endometriomas who did not conceive, six had well-documented male factor  infertility.","15136074, 15136074, 21561807, 21561807, 21561807, 2943896","Yes, endometrioma surgery seems to improve the success rates of fertility treatment.","12419041, 15136074, 17399914, 23759693, 21561807, 8737616, 16034960, 7202738, 21679474, 18425908, 21764126, 2943896, 11526777, 22695290, 23277022, 24231199"
Which enzyme is targeted by Evolocumab?,"Yes, the enzyme targeted by Evolocumab is proprotein convertase subtilisin/kexin type 9 (PCSK9). Evolocumab is a fully human monoclonal antibody","Context: tolerate statins or full doses of these drugs. Thus, there is a need for  additional effective LDL-C reducing agents. AREAS COVERED: Evolocumab (AMG145) is a monoclonal antibody inhibiting the, Context: METHODS: This multicentre, randomised, double-blind, placebo-controlled trial  was undertaken at 39 sites (most of which were specialised lipid clinics, mainly  attached to academic institutions) in Australia, Asia, Europe, New Zealand,, Context: action are in advanced phase of development or have just been approved. AREAS COVERED: Evolocumab and alirocumab are fully human monoclonal antibodies  inhibiting the proprotein convertase subtilisin/kexin type 9 (PCSK9) that binds, Context: action are in advanced phase of development or have just been approved. AREAS COVERED: Evolocumab and alirocumab are fully human monoclonal antibodies  inhibiting the proprotein convertase subtilisin/kexin type 9 (PCSK9) that binds, Context: action are in advanced phase of development or have just been approved. AREAS COVERED: Evolocumab and alirocumab are fully human monoclonal antibodies  inhibiting the proprotein convertase subtilisin/kexin type 9 (PCSK9) that binds, Context: action are in advanced phase of development or have just been approved. AREAS COVERED: Evolocumab and alirocumab are fully human monoclonal antibodies  inhibiting the proprotein convertase subtilisin/kexin type 9 (PCSK9) that binds","24661068, 25282519, 24961142, 24961142, 24961142, 24961142",Evolocumab (AMG145) is a fully human monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9) that demonstrated marked reductions in plasma low-density lipoprotein cholesterol concentrations in statin-intolerant patients.,"24859266, 24694531, 24662398, 24691094, 25470376, 24825642, 24953393, 25079474, 24953396, 25002170, 24678979, 24598985, 24661068, 24477778, 24481874, 24255061, 25282519, 25282520, 24509273, 25052769, 24284914, 24373748, 24961142, 25410046"
Which annotated database of A-to-I RNA editing is available?,"Yes, RADAR is an annotated database of A-to-I RNA editing available at <http://RNAedit.com>. It includes a comprehensive collection of A-to-I RNA editing sites identified in humans,","Context: We present RADAR--a rigorously annotated database of A-to-I RNA editing  (available at http://RNAedit.com). The identification of A-to-I RNA editing  sites has been dramatically accelerated in the past few years by high-throughput, Context: We present RADAR--a rigorously annotated database of A-to-I RNA editing  (available at http://RNAedit.com). The identification of A-to-I RNA editing  sites has been dramatically accelerated in the past few years by high-throughput, Context: RNA sequencing studies. RADAR includes a comprehensive collection of A-to-I RNA  editing sites identified in humans (Homo sapiens), mice (Mus musculus) and flies  (Drosophila melanogaster), together with extensive manually curated annotations, Context: RNA sequencing studies. RADAR includes a comprehensive collection of A-to-I RNA  editing sites identified in humans (Homo sapiens), mice (Mus musculus) and flies  (Drosophila melanogaster), together with extensive manually curated annotations, Context: The RNA editing enzyme ADAR chemically modifies adenosine (A) to inosine (I),  which is interpreted by the ribosome as a guanosine. Here we assess  cotranscriptional A-to-I editing in Drosophila by isolating nascent RNA from, Context: affecting editing of 16 A-to-I editing sites (cis-RNA editing quantitative trait  loci or cis-edQTLs, P < 10(-8)). The observed changes in editing levels are  validated by independent molecular technique. All identified regulatory variants","24163250, 24163250, 24163250, 24163250, 22658416, 26656153","RADAR is a rigorously annotated database of A-to-I RNA editing. RADAR includes a comprehensive collection of A-to-I RNA editing sites identified in humans (Homo sapiens), mice (Mus musculus) and flies (Drosophila melanogaster), together with extensive manually curated annotations for each editing site. RADAR also includes an expandable listing of tissue-specific editing levels for each editing site, which will facilitate the assignment of biological functions to specific editing sites.",24163250
List interaction partners for the protein GATA1.,"Yes, according to the context, GATA1 interacts with LMO2-C. This was determined through MBP pull down analysis, where endogenous GATA1 proteins were confirmed to bind to LMO2-C.","Context: characters of its developers' nicknames), is presented. GIBA implements a two  step procedure to a given dataset of protein-protein interaction data. First, a  clustering algorithm is applied to the interaction data, which is then followed, Context: OBJECTIVE: To identify the interaction partners of a new splicing product of  LMO2 gene (LMO2-C), and study its function in K562 cells. METHODS: Maltose binding protein (MBP) pull down and mammalian two-hybrid assay, Context: (ii) GATA-1, instead of Gfi-1B, binds directly to the Gfi-1-like sites in the  Gfi-1B promoter and (iii) Gfi-1B suppresses GATA-1-mediated stimulation of  Gfi-1B promoter through their protein interaction. These results not only, Context: (ii) GATA-1, instead of Gfi-1B, binds directly to the Gfi-1-like sites in the  Gfi-1B promoter and (iii) Gfi-1B suppresses GATA-1-mediated stimulation of  Gfi-1B promoter through their protein interaction. These results not only, Context: RESULTS: MBP-LMO2-C fusion protein was expressed and purified in soluble form  successfully. Endogenous GATA1 and LDB1 proteins were confirmed to bind to  LMO2-C by MBP pull down analysis. The MTHA also showed that LMO2-C had, Context: RESULTS: MBP-LMO2-C fusion protein was expressed and purified in soluble form  successfully. Endogenous GATA1 and LDB1 proteins were confirmed to bind to  LMO2-C by MBP pull down analysis. The MTHA also showed that LMO2-C had","19534736, 18844071, 16177182, 16177182, 18844071, 18844071","GATA-1 interact with factor Gfi-1b, the repressive MeCP1 complex, the chromatin remodeling ACF/WCRF complex, FOG-1, TAL-1, Ldb-1 and LMO2-C.","16339652, 17108004, 18844071, 15542823, 12032775, 21532337, 20959602, 15920471"
Which proteins does RG-7992 target?,"No, the context does not provide information about which proteins RG-7992 targets. The context only mentions that RG7112 is a potent and selective member of the nutlin family of MDM2","Context: chronic pancreatitis (n = 3), and pancreatic cancer (n = 3). RESULTS: We identified 525 nonredundant proteins from 9 specimens. Implementing  our filtering criteria, 78, 15, and 21 proteins were identified exclusively in, Context: Nuclear speckles (NSs) serve as splicing factor storage sites. In this study, we  unexpectedly found that many endogenous intronless mRNAs, which do not undergo  splicing, associate with NSs. These associations do not require transcription,, Context: blueprint for both targets. However, pitolisant as selective H3R inverse agonist  with FDA and EMA-approval did not show the required inhibition at G9a.  Pharmacological characterization of the prominent G9a inhibitor A-366, that is, Context: cancer therapy. RG7112 is a potent and selective member of the nutlin family of  MDM2 antagonists currently in phase I clinical studies. RG7112 binds MDM2 with  high affinity (K(D) ~ 11 nmol/L), blocking its interactions with p53 in vitro. A, Context: cancer therapy. RG7112 is a potent and selective member of the nutlin family of  MDM2 antagonists currently in phase I clinical studies. RG7112 binds MDM2 with  high affinity (K(D) ~ 11 nmol/L), blocking its interactions with p53 in vitro. A, Context: cancer therapy. RG7112 is a potent and selective member of the nutlin family of  MDM2 antagonists currently in phase I clinical studies. RG7112 binds MDM2 with  high affinity (K(D) ~ 11 nmol/L), blocking its interactions with p53 in vitro. A","22015969, 30194269, 32782417, 23400593, 23400593, 23400593",BFKB8488A is a bispecific antibody against FGFR1 and KLB.,33139537
Is Tranexamic acid effective for intracerebral haemorrhage?,"Yes, tranexamic acid has been shown to be an effective haemostatic agent in reducing post-operative and traumatic bleeding. However, its effect on post-intracerebral haemorrhage seizures","Context: INTRODUCTION: Seizures are common after intracerebral haemorrhage. Tranexamic  acid increases the risk of seizures in non-intracerebral haemorrhage population  but its effect on post-intracerebral haemorrhage seizures is unknown. We, Context: PURPOSE: Haematoma expansion is a devastating complication of intracerebral  haemorrhage (ICH) with no established treatment. Tranexamic acid had been an  effective haemostatic agent in reducing post-operative and traumatic bleeding., Context: PURPOSE: Haematoma expansion is a devastating complication of intracerebral  haemorrhage (ICH) with no established treatment. Tranexamic acid had been an  effective haemostatic agent in reducing post-operative and traumatic bleeding., Context: PURPOSE: Haematoma expansion is a devastating complication of intracerebral  haemorrhage (ICH) with no established treatment. Tranexamic acid had been an  effective haemostatic agent in reducing post-operative and traumatic bleeding., Context: PURPOSE: Haematoma expansion is a devastating complication of intracerebral  haemorrhage (ICH) with no established treatment. Tranexamic acid had been an  effective haemostatic agent in reducing post-operative and traumatic bleeding., Context: PURPOSE: Haematoma expansion is a devastating complication of intracerebral  haemorrhage (ICH) with no established treatment. Tranexamic acid had been an  effective haemostatic agent in reducing post-operative and traumatic bleeding.","32637645, 31008298, 31008298, 31008298, 31008298, 31008298",No. According to clinical trial data tranexamic acid does not improve outcomes of patients with intracerebral haemorrhage.,"31322116, 31008298, 32637645, 33128912, 29778325"
Which pathway is activated by ficolin-3?,"Yes, ficolin-3 activates the lectin complement pathway. This is because ficolin-3 is a molecule that can initiate the lectin pathway of complement activation and is resistant to collagenase proteol","Context: in the assay independent of the Ficolin-3 concentration., Context: complement activating potential and is the only collagenase proteolytic  resistant molecule among the lectin complement pathway initiators., Context: activation, while ficolin-3 is the most abundant ficolin molecule in the  circulation. The significance of lectin pathway complexes in the circulation is  unknown. Thus, we established an assay for the measurement of circulating, Context: activation, while ficolin-3 is the most abundant ficolin molecule in the  circulation. The significance of lectin pathway complexes in the circulation is  unknown. Thus, we established an assay for the measurement of circulating, Context: calcium. Ficolin-3 also augmented phagocytosis of H. alvei by macrophages and  displayed bactericidal activity. Additionally, Ficolin-3 inhibited host cells'  response to TLR4/MD-2/CD14-LPS dependent NF-κB activation. This is the first, Context: calcium. Ficolin-3 also augmented phagocytosis of H. alvei by macrophages and  displayed bactericidal activity. Additionally, Ficolin-3 inhibited host cells'  response to TLR4/MD-2/CD14-LPS dependent NF-κB activation. This is the first","25069872, 18006063, 23142462, 23142462, 25178935, 25178935",Ficolin-3 activates lectin complement pathway.,"18261799, 19939495, 21890891, 24336142, 18006063, 25069872, 25178935, 19535802, 23142462"
What animal is thought to be the host for the Coronavirus causing MERS?,"Yes, according to the context, dromedary camels are thought to be the host for the Coronavirus causing MERS. The text states that ""little is known about MERS-CoV animal host range"" but also ment","Context: Two novel coronaviruses have emerged to cause severe disease in humans. While  bats may be the primary reservoir for both viruses, SARS coronavirus (SARS-CoV)  likely crossed into humans from civets in China, and MERS coronavirus (MERS-CoV), Context: in the transmission of pathogens is of importance to understand the epidemiology  of the disease. Little is known about MERS-CoV animal host range. In this paper,  experimental data on potential hosts for MERS-CoV is reviewed. Advantages and, Context: Coronavirus (CoV) infections are commonly associated with respiratory and  enteric disease in humans and animals. In 2012, a new human disease called  Middle East respiratory syndrome (MERS) emerged in the Middle East. MERS was, Context: against emerging viruses. With SARS-CoV, several animal species were permissive  to infection. In contrast, most laboratory animals are refractory or only  semi-permissive to infection with MERS-CoV. This host-range restriction is, Context: against emerging viruses. With SARS-CoV, several animal species were permissive  to infection. In contrast, most laboratory animals are refractory or only  semi-permissive to infection with MERS-CoV. This host-range restriction is, Context: against emerging viruses. With SARS-CoV, several animal species were permissive  to infection. In contrast, most laboratory animals are refractory or only  semi-permissive to infection with MERS-CoV. This host-range restriction is","25791336, 28616501, 30146782, 25791336, 25791336, 25791336",The animal thought to be the host for the Coronavirus causing MERS is camels.,"25791336, 29239118, 29336306, 30146782"
Describe RCandy,"Yes, RCandy is a platform-independent R package for visualizing recombination events in bacterial genomes. It is available under the MIT license and has been tested on Windows, Linux, and MacOSX. The source code is","Context: detect genomic regions recently affected by recombination. Exploration and  visualization of such recombination events can reveal valuable biological  insights, but it remains challenging. Here, we present RCandy, a, Context: under the MIT license. It is platform-independent and has been tested on  Windows, Linux and MacOSX. The source code comes together with a detailed  vignette available on GitHub at https://github.com/ChrispinChaguza/RCandy., Context: platform-independent R package for rapid, simple and flexible visualization of  recombination events in bacterial genomes. AVAILABILITY AND IMPLEMENTATION: RCandy is an R package freely available for use, Context: platform-independent R package for rapid, simple and flexible visualization of  recombination events in bacterial genomes. AVAILABILITY AND IMPLEMENTATION: RCandy is an R package freely available for use, Context: platform-independent R package for rapid, simple and flexible visualization of  recombination events in bacterial genomes. AVAILABILITY AND IMPLEMENTATION: RCandy is an R package freely available for use, Context: under the MIT license. It is platform-independent and has been tested on  Windows, Linux and MacOSX. The source code comes together with a detailed  vignette available on GitHub at https://github.com/ChrispinChaguza/RCandy.","34864895, 34864895, 34864895, 34864895, 34864895, 34864895","RCandy is a platform-independent R package for rapid, simple, and flexible visualisation of recombination events in bacterial genomes.",34864895
Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?,"Yes, a polymorphism in the TNFR2 gene is associated with Systemic Lupus Erythematosus (SLE). Specifically, the allele coding for Arg at the position 196 of the","Context: study were to examine the TNFR2 polymorphism in Japanese patients with SLE and  to investigate its association with other autoimmune diseases accompanied by  vasculitis, mixed connective tissue disease, Buerger's disease, and Takayasu's, Context: represents an apparent discrepancy. The association, then, should be tested in  other populations to clarify the possible involvement, if any, of the TNFR2  polymorphism in SLE or other related autoimmune diseases. The purposes of this, Context: A polymorphism in high-affinity receptor of TNF (TNFR2) gene, Met196Arg, was  reported to be associated with systemic lupus erythematosus (SLE) in Japanese,  whereas the association could not be found in Europeans at all and this, Context: A polymorphism in high-affinity receptor of TNF (TNFR2) gene, Met196Arg, was  reported to be associated with systemic lupus erythematosus (SLE) in Japanese,  whereas the association could not be found in Europeans at all and this, Context: A number of studies reported associations of HLA-DRB1, TNFalpha (TNF) promoter  and TNF receptor II (TNFR2, TNFRSF1B) polymorphisms with systemic lupus  erythematosus (SLE), however, the results have often been inconsistent. Such, Context: We recently reported the association of the allele coding for Arg at the  position 196 (196R: nucleotide [nt] 587G) of tumor necrosis factor receptor 2  (TNFR2, TNF-R75) with systemic lupus erythematosus (SLE) in Japanese. In the","11169260, 11169260, 11169260, 11169260, 11607787, 11197692",There is a TNFR2 3' flanking region polymorphism in systemic lupus erythematosus.,"11607787, 11169260, 11196716, 11197692, 10395102"
Which resource has been developed in order to study the transcriptional regulation of GABAergic cell fate?,"No, the context does not mention any resource for studying the transcriptional regulation of GABAergic cell fate. The context discusses various resources and studies related to T-cell fate decision processes, kinases, cardiac progenitor","Context: transcription of these 26 Th2-specific genes, and 10 genes showed increased  transcription in a GATA3-dependent manner, whereas 16 genes showed no  significant responses. The transcription of the 16 GATA3-nonresponding genes was, Context: coreceptors, CD4 and CD8. In the past few decades, extensive effort has been  made to understand the T-cell fate decision processes by studying regulation of  genes encoding the coreceptors and selection processes. These studies have, Context: abnormal gene regulation during the development of hematopoietic cells. The  CD4(+) helper versus CD8(+) cytotoxic T-cell fate decision serves as an  excellent model to study binary fate decision processes. These two cell types, Context: transitions are associated with distinct open chromatin states critically  depending on Isl1 and Nkx2-5. Our data provide a model of transcriptional and  epigenetic regulations during cardiac progenitor cell fate decisions at  single-cell resolution., Context: identified several key transcription factors and gene regulatory networks. In  this chapter, I will discuss recent advances in our understanding of the binary  cell fate decision processes of T cells., Context: kinases (IRAK) regulates responsiveness to bacterial endotoxins. Pharmacological  targeting of particular IRAK components may be beneficial for treatment of  bacterial infections. Here, we studied transcriptional regulation of the human","21536806, 25591463, 25591463, 30451828, 25591463, 15670593",Subpallial Enhancer Transgenic Lines is a data and tool resource to study transcriptional regulation of GABAergic cell fate.,27710791
In which cellular compartment do stress granules localize?,"Yes, stress granules localize in the cytoplasm. This is stated explicitly in multiple parts of the context.","Context: cytoplasmic foci (i.e. stress granules) colocalized with the mutant FUS  inclusions but were absent in wild-type FUS-expressing cells. Processing bodies,  which are functionally related to stress granules, were adjacent to but not, Context: domains within FUS play a key role in its association to stress granules. While  there has been speculation that arginine methylation within these RGG domains  modulates the incorporation of FUS into stress granules, our results demonstrate, Context: Stress granules (SGs) are cytoplasmic granules that are formed in cells when  stress occurs. In this study, we found that SGs formed in cells infected with  coxsackievirus B3 (CVB3), evidenced with the co-localization of some accepted SG, Context: number of cell types. We have found that PABP4, similarly to PABP1, is a  diffusely cytoplasmic protein that can be localised to stress granules. However,  UV exposure unexpectedly relocalised both proteins to the nucleus. Nuclear, Context: Stress granules (SGs) are RNA-containing cytoplasmic foci formed in response to  stress exposure. Since their discovery in 1999, over 120 proteins have been  described to be localized to these structures (in 154 publications). Most of, Context: cytoplasm. Cytoplasmic FUS was recruited into stress granules, which showed a  time-dependent decrease in all subjects. However, in the FUS P525L fibroblasts,  the granules persisted longer, and they were more numerous than those detected","20674093, 24090136, 25148713, 21940797, 26557057, 29035885",cytoplasm,"29298433, 23474818, 27057671, 25148713, 29035885, 28894257, 23982513, 22383896"
Entresto is composed of which two drugs?,"Yes, Entresto is composed of valsartan and sacubitril. Valsartan is an angiotensin receptor blocker (ARB) while sacubitril is a neprilysin inhibitor prod","Context: sociales y el desarrollo profesional. El gen más frecuentemente afectado en la  quilomicronemia familiar es el de lipoproteína lipasa-1 (LPL), enzima que  hidroliza triglicéridos circulantes para su captación tisular. Mutaciones en, Context: (entresto) for possible treatment of HFrEF. CONCLUSION: In this article, we will discuss the failure of previous treatment  modalities and the promise that LCZ696 (entresto) may hold for treating patients  with HFpEF., Context: polymorph of the active pharmaceutical ingredient (API). This positive change in  regulatory perspective coupled with successful commercialization of  valsartan-sacubitril co-crystal (Entresto, Novartis) has now brought co-crystals, Context: Sacubitril/valsartan (Entresto™; LCZ696) is an orally administered  supramolecular sodium salt complex of the neprilysin inhibitor prodrug  sacubitril and the angiotensin receptor blocker (ARB) valsartan, which was, Context: as LCZ696 and currently marketed by Novartis as Entresto) combines the  angiotensin receptor blocker valsartan and the neprilysin inhibitor prodrug  sacubitril in a 1:1 ratio in a sodium supramolecular complex. Sacubitril is, Context: as LCZ696 and currently marketed by Novartis as Entresto) combines the  angiotensin receptor blocker valsartan and the neprilysin inhibitor prodrug  sacubitril in a 1:1 ratio in a sodium supramolecular complex. Sacubitril is","32841138, 28676030, 29352367, 26873495, 26976916, 26976916","Entresto is composed of sacubitril and valsartan. It is newly FDA-approved medication that dually inhibits angiotensin and neprilysin, in the treatment of heart failure.","27378659, 27804100, 26992459, 26976916, 26417173, 27697814, 26873495, 27284124, 26466333, 26642078, 26975167"
What is the genetic basis of Rubinstein-Taybi syndrome?,"Yes, the genetic basis of Rubinstein-Taybi syndrome (RSTS) includes point mutations or deletions in the CREBBP gene located at 16p13.3. This gene encodes a transcription","Context: Familial Rubinstein-Taybi syndrome (RTS) is very rare. Here we report on the 6th  and 7th case of inherited RTS. Family 1 presents with incomplete or mild RTS  over three generations; a 13-year-old girl (proband 1) with mild but typical, Context: young children. This case report demonstrates the ability of array-based  comparative genomic hybridization to offer a genome-wide analysis at high  resolution and provide information directly linked to the physical and genetic, Context: Rubinstein-Taybi syndrome (RSTS) is a rare autosomal dominant disorder  characterised by facial dysmorphisms, growth and psychomotor development delay,  and skeletal defects. The known genetic causes are point mutations or deletions, Context: a cause of Rubinstein-Taybi syndrome. However, microdeletion of 16 p13.3  comprising cyclic adenosine monophosphate-response element-binding protein and  tumor necrosis factor receptor-associated protein 1 genes is a rare scenario in, Context: is essential for normal development, since inactivation of one allele causes  Rubinstein-Taybi syndrome (RSTS). There is a direct link between loss of acetyl  transferase activity and RSTS, which indicates that the disorder is caused by, Context: the pathogenesis of Rubinstein-Taybi syndrome. Additionally, due to insufficient  coverage of the human genome by conventional techniques, clinically significant  genomic imbalances may be undetected in unexplained syndromic conditions of","20684013, 22269667, 20125191, 22269667, 15706485, 22269667","Rubinstein-Taybi syndrome (RTS) is a rare autosomal dominant disorder (prevalence 1:125,000) characterised by broad thumbs and halluces, facial dysmorphism, psychomotor development delay, skeletal defects, abnormalities in the posterior fossa and short stature. The known genetic causes are a microdeletion at 16p13.3 or mutations or deletions of the cAMP-response element binding protein-BP (CREBBP) (50-60% of the cases) and of the homologous gene E1A-binding protein (EP300) at 22q13 (5%). Direct sequencing of CREBBP performed in 13 RSTS patients identified the three zinc fingers (CH1, CH2, CH3) and HAT domain as mutational hotspots. Thus about 55% of patients have cytogenetic or molecular abnormalities in the Crebbp or E1A binding protein p300 (Ep300) gene, leaving the diagnosis in 45% of patients to rest on clinical features only.","7630403, 16359492, 22269667, 14974086, 18773673, 20684013, 23432975, 22303793, 15706485, 20689175, 22991675"
What are the biological roles proposed for proteins containing the SPRY domain?,"Yes, the SPRY domain is involved in regulating innate and adaptive immunity. This is because it's a protein interaction module found in 77 murine and ~100 human proteins that play crucial roles in","Context: The SPRY domain is a protein interaction module found in 77 murine and ~100  human proteins, and is implicated in important biological pathways, including  those that regulate innate and adaptive immunity. The current definition of the, Context: The SPRY domain is a protein interaction module found in 77 murine and ~100  human proteins, and is implicated in important biological pathways, including  those that regulate innate and adaptive immunity. The current definition of the, Context: The SPRY domain is a protein interaction module found in 77 murine and ~100  human proteins, and is implicated in important biological pathways, including  those that regulate innate and adaptive immunity. The current definition of the, Context: The SPRY domain is a protein interaction module found in 77 murine and ~100  human proteins, and is implicated in important biological pathways, including  those that regulate innate and adaptive immunity. The current definition of the, Context: The SPRY domain is a protein interaction module found in 77 murine and ~100  human proteins, and is implicated in important biological pathways, including  those that regulate innate and adaptive immunity. The current definition of the, Context: The SPRY domain is a protein interaction module found in 77 murine and ~100  human proteins, and is implicated in important biological pathways, including  those that regulate innate and adaptive immunity. The current definition of the","23139046, 23139046, 23139046, 23139046, 23139046, 23139046",defence against retroviral infection innate and adaptative immunity vesicular trafficking neural differentiation embryonic development,"12479811, 16648259, 16226405, 23139046, 22872646, 16313355, 15857996, 21035437, 23775985, 23886867, 15689398, 19184407, 23091002, 22337885, 17431422"
Can the yeast protein Abf1 act as insulator?,"Yes, based on the context, the yeast protein Abf1 can act as an insulator. This is stated explicitly in the context where it mentions that ""Saccharomyces cerevisiae Rap1p and Abf1","Context: and other derived nematodes does so. CONCLUSION: Our findings show that CTCF and possibly chromatin insulation are  present in basal nematodes. We suggest that the insulator protein CTCF has been, Context: Abf1 binding sites in the promoters of mitochondrial RP genes evokes the  possibility that Abf1 might orchestrate still unexplored levels of co-regulation  involving growth-related gene networks in yeast cells., Context: Abf1 and Rap1 are general regulatory factors (GRFs) that contribute to  transcriptional activation of a large number of genes, as well as to  replication, silencing and telomere structure in yeast. In spite of their, Context: Abf1 and Rap1 are general regulatory factors (GRFs) that contribute to  transcriptional activation of a large number of genes, as well as to  replication, silencing and telomere structure in yeast. In spite of their, Context: factors. Rif1 has recently been identified as a genome-wide regulator of  replication timing in fission yeast and in mammalian cells. However, previous  studies in budding yeast have suggested that Rif1's role in controlling, Context: Insulators are sequences that uncouple adjacent chromosome domains. Here we have  shown that Saccharomyces cerevisiae Rap1p and Abf1p proteins are endowed with a  potent insulating capacity. Insulating domains in Rap1p coincide with previously","19712444, 27262581, 17158163, 17158163, 24879017, 12200417",Saccharomyces cerevisiae Rap1p and Abf1p proteins are endowed with a potent insulating capacity,12200417
Which viruses are best known to cause myocarditis?,"Yes, Coxsackie B viruses (types 1 to 5) are best known to cause myocarditis. The context mentions that these viruses are the most frequent reported cause of acute viral myocard","Context: Enteroviruses have been considered to be the most common cause of acute  myocarditis and possible consequence of dilated cardiomyopathy. Some  publications shed light to the role of other viruses in this disease as well., Context: CASE PRESENTATION: We report the cases of two pregnant Caucasian women (aged 29  and 30), with no pre-existing illness, presenting with respiratory  manifestations of H1N1 influenza virus infection in their third trimester. Both, Context: Coxsackie B viruses (types 1 to 5) are the most frequent reported cause of acute  viral myocarditis. To study the pathogenesis of the disease at the cellular  level, we simulated an infectious situation by infecting cultured human foetal, Context: other recovered without any long-term consequence. CONCLUSIONS: While it is not possible to ascertain retrospectively if  myocarditis was caused by either infection with H1N1 virus or as a result of, Context: other recovered without any long-term consequence. CONCLUSIONS: While it is not possible to ascertain retrospectively if  myocarditis was caused by either infection with H1N1 virus or as a result of, Context: enhancement, histopathologic analysis revealed active myocarditis in 19 patients  (parvovirus B19, n=12; human herpes virus type 6 [HHV 6], n=5). Conversely, in  the remaining 11 patients, in whom biopsy could not be taken from the region of","18039618, 21756329, 3889351, 21756329, 21756329, 14993139","The most frequent viruses causing myocarditis are Enterovirus, Adenovirus and Coxsackie B viruses.","18039618, 8199011, 18277927, 3889351, 2641165, 14993139"
What is the relationship between thyroid hormone and inflammatory markers in heart failure patients?,"Yes, there seems to be a relationship between thyroid hormones and inflammatory markers in heart failure patients. The context suggests that cytokines, which are involved in the inflammatory response, are associated with bioc","Context: Cytokines and thyroid hormones are involved in the biochemical changes  associated to heart failure (HF). AIM: Aims of the study were to investigate: plasma circulating levels of the, Context: indicate that thyroid hormone metabolism (ie, the triiodothyronine to reverse  triiodothyronine ratio) is altered in a majority of patients with advanced  congestive heart failure and is an independent predictor of mortality. Currently, Context: Interest in the role of thyroid hormones (TH) in heart failure is steadily  increasing due to evidence for a physiological, homeostatic role of TH and the  effects of altered TH metabolism on the cardiovascular system, particularly in, Context: functional status in patients with heart failure. These data probably indicate a  possible role of thyroid hormone in the pathophysiology of heart failure and  confirm previous experimental reports., Context: significance of altered thyroid hormone concentrations, the course of thyroid  abnormalities in congestive heart failure survivors, and the potential  relationship of thyroid abnormalities to overall metabolic rate. Our results, Context: Though thyroid hormone abnormalities have been identified in many cardiac  conditions, the role of thyroid hormones in congestive heart failure has not  been well defined. In a population of patients with advanced heart failure, a","19926244, 8333797, 18221125, 17893267, 8333797, 8936683",There is an inverse correlation between inflammatory markers (IL-6 and TNF alfa and PCR) and FT3 levels in patients with heart failure,"16524802, 19926244, 11021766, 15259379, 15521205, 12165115"
Is thrombophilia related to increased risk of miscarriage?,"Yes, thrombophilia is related to an increased risk of miscarriage. The context states that thrombophilia was found to be considerably more common in women with pregnancy-associated complications, which can include spontaneous abortion","Context: mainly associated with the risk of spontaneous abortion during the first  trimester. In conclusion, thrombophilia was found to be considerably more common  in women with pregnancy-associated complications in comparison with the general, Context: macrovascular function were determined. RESULTS: Women with thrombophilia had significant lower total- and low-density  cholesterol, were more insulin sensitive, and had better microvascular function., Context: OBJECTIVE: Preeclampsia is associated with increased risk of cardiovascular  disease. The aim of this pilot study was to assess whether the presence of  thrombophilia results in a greater tendency to develop endothelial dysfunction, Context: Thrombophilias have been implicated in complications related to ischemic  placental disease including recurrent pregnancy loss, intrauterine fetal demise,  preeclampsia, fetal growth restriction, placental abruption, and preterm, Context: PURPOSE: To determine if thrombophilia is a risk factor for placenta-mediated  pregnancy complications (PMPC) (i.e., preeclampsia, intrauterine growth  restriction (IUGR), placental abruption, intrauterine fetal death and recurrent  pregnancy loss)., Context: RESULTS: Sixty women (34.9%) showed the presence of a thrombophilic defect. They  had a higher risk for the recurrence of preeclampsia (odds ratio [OR], 2.5; 95%  confidence interval [CI], 1.2-5.1), compared to patients without thrombophilia.","19031171, 20860491, 20860491, 21380983, 22543699, 18845284","Thrombophilia has been found to be considerably more common in women with pregnancy-associated complications in comparison with the general population, and most frequently in conjunction with venous thromboembolism during pregnancy and the postpartum period. In particular there is an increased risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. When counseling white women with a history of preeclampsia, screening for thrombophilia can be useful for preconceptional counseling and pregnancy management.","19031171, 18845284, 16962918, 19165673, 20860491, 11583310, 7986734, 22543699, 19135285, 22164918, 21380983, 15713144, 15027582"
Has Hesperidin any role as a Neuroprotective Agent?,"Yes, hesperidin has a neuroprotective role. The context indicates that hesperidin, a plant-derived bioflavonoid, may be a candidate for neuroprotective treatment in the retina due to","Context: activities of enzymatic antioxidants, upregulation of Bax, cyt c, and caspases 3  and 9, and downregulation of Bcl-2, which were attenuated in the presence of  hesperidin. Our data suggests that hesperidin exerts its neuroprotective effect, Context: Emerging evidences indicate hesperidin, a citrus flavanone, attenuates  neurodegenerative processes and related complications. Besides its anti-oxidant  properties, the other probable mechanisms which underpin its neuroprotective, Context: We found that hesperidin, a plant-derived bioflavonoid, may be a candidate agent  for neuroprotective treatment in the retina, after screening 41 materials for  anti-oxidative properties in a primary retinal cell culture under oxidative, Context: potential are still not clear. In light of emerging role of flavonoids in  modulating oxidative stress and neuro-inflammation, the study has been designed  to explore the possible neuroprotective effect of hesperidin and its combination, Context: potential are still not clear. In light of emerging role of flavonoids in  modulating oxidative stress and neuro-inflammation, the study has been designed  to explore the possible neuroprotective effect of hesperidin and its combination, Context: evaluate the potential role of hesperidin in glutamate release and glutamate  neurotoxicity in the hippocampus of rats. In rat hippocampal nerve terminals  (synaptosomes), hesperidin inhibited the release of glutamate and elevation of","24205431, 24211676, 28761134, 24211676, 24211676, 26342684",Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer's disease,"28721824, 29687202, 30448580, 26381129, 24987179, 28761134, 22383310, 25860498, 30352242, 29136946, 21445621, 26342684, 24205431, 24211676, 16964766, 22850463"
Which disease the skin condition Necrobiosis lipoidica diabeticorum is associated to?,"Yes, Necrobiosis Lipoidica Diabeticorum is associated with diabetes mellitus. This is mentioned in the context as it states that ""Necrobiosis lipoidica diabeticorum is a rare skin disorder","Context: diabeticorum or the clinical course of the lesion. We base our challenge to this  position on a critical review of the original data. And conclude on the  contrary, that necrobiosis lipoidica diabeticorum is usually associated with, Context: Necrobiosis lipoidica diabeticorum is a rare skin disorder, usually considered a  marker for diabetes mellitus. More than half of the patients with necrobiosis  lipoidica diabeticorum have diabetes mellitus, but less than one per cent of, Context: Necrobiosis lipoidica diabeticorum is a rare skin disorder, usually considered a  marker for diabetes mellitus. More than half of the patients with necrobiosis  lipoidica diabeticorum have diabetes mellitus, but less than one per cent of, Context: Necrobiosis lipoidica diabeticorum is a rare skin disorder, usually considered a  marker for diabetes mellitus. More than half of the patients with necrobiosis  lipoidica diabeticorum have diabetes mellitus, but less than one per cent of, Context: Necrobiosis lipoidica is an idiopathic dermatological condition that is strongly  associated with diabetes mellitus. It is more commonly seen in women than men.  The average age of onset is 30-40 years. Necrobiosis Lipoidica diabeticorum is, Context: necrobiosis lipoidica diabeticorum with other chronic complications of diabetes  mellitus, including limited joint mobility. It is possible that nonenzymatic  glucosylation or other changes in collagen may be important in the etiology of","8733162, 8733162, 8733162, 8733162, 18718195, 3351015","Necrobiosis lipoidica diabeticorum (NLD) is a rare, granulomatous inflammatory skin disease of unknown origin, sometimes associated with diabetes mellitus.","23969033, 11259927, 12180894, 16060710, 12183729, 27016885, 19380665, 24575162, 20524475, 26975548, 18357585, 17429587, 2102235, 23762652, 24283101, 18092383, 3351015, 8733162, 7501550, 20537071, 730866, 19715570, 25266162, 18718195, 23595890, 7851128, 8261754, 18377597"
Which receptors does bimagrumab block?,"Yes, bimagrumab blocks activin type II receptors. This is stated explicitly in the context as one of the main mechanisms of action of this drug. Bimagrumab is a human monoclonal antibody inhibitor of","Context: RATIONALE: Bimagrumab is a fully human monoclonal antibody that blocks the  activin type II receptors, preventing the activity of myostatin and other  negative skeletal muscle regulators., Context: BACKGROUND: Bimagrumab is a human monoclonal antibody inhibitor of activin type  II receptors (ActRII), with anabolic action on skeletal muscle mass by blocking  binding of myostatin and other negative regulators of muscle growth. Bimagrumab, Context: Bimagrumab (BYM338) is a novel fully human monoclonal antibody that exerts  strong promyogenic effects on skeletal muscle by blocking activin type II  receptors (ActRII). We investigated whether such blockade of ActRII by, Context: Bimagrumab (BYM338) is a novel fully human monoclonal antibody that exerts  strong promyogenic effects on skeletal muscle by blocking activin type II  receptors (ActRII). We investigated whether such blockade of ActRII by, Context: BACKGROUND: Bimagrumab is a human monoclonal antibody inhibitor of activin type  II receptors (ActRII), with anabolic action on skeletal muscle mass by blocking  binding of myostatin and other negative regulators of muscle growth. Bimagrumab, Context: mild in severity. CONCLUSIONS: Blocking the action of negative muscle regulators through the  activin type II receptors with bimagrumab treatment safely increased skeletal  muscle mass but did not improve functional capacity in patients with COPD and","30095981, 29566437, 27167138, 27167138, 29566437, 30095981",Bimagrumab blocks the activin type II receptors.,30095981
Is Sotatercept effective for Pulmonary Arterial Hypertension?,"Yes, sotatercept is effective in reducing pulmonary vascular resistance in patients with pulmonary arterial hypertension. This conclusion is based on a 24-week multicenter trial where adults receiving background therapy for","Context: METHODS: In this 24-week multicenter trial, we randomly assigned 106 adults who  were receiving background therapy for pulmonary arterial hypertension to receive  subcutaneous sotatercept at a dose of 0.3 mg per kilogram of body weight every 3, Context: BACKGROUND: Pulmonary arterial hypertension is characterized by pulmonary  vascular remodeling, cellular proliferation, and poor long-term outcomes.  Dysfunctional bone morphogenetic protein pathway signaling is associated with, Context: METHODS: In this 24-week multicenter trial, we randomly assigned 106 adults who  were receiving background therapy for pulmonary arterial hypertension to receive  subcutaneous sotatercept at a dose of 0.3 mg per kilogram of body weight every 3, Context: patient in the sotatercept 0.7-mg group died from cardiac arrest. CONCLUSIONS: Treatment with sotatercept resulted in a reduction in pulmonary  vascular resistance in patients receiving background therapy for pulmonary, Context: patient in the sotatercept 0.7-mg group died from cardiac arrest. CONCLUSIONS: Treatment with sotatercept resulted in a reduction in pulmonary  vascular resistance in patients receiving background therapy for pulmonary, Context: least-squares mean difference between the sotatercept 0.3-mg group and the  placebo group in the change from baseline to week 24 in pulmonary vascular  resistance was -145.8 dyn · sec · cm-5 (95% confidence interval [CI], -241.0 to","33789009, 33789009, 33789009, 33789009, 33789009, 33789009",Sotatercept was shown to be effective for Pulmonary Arterial Hypertension.,"33789009, 33733610"
List mutations that are implicated in the Gray Platelet Syndrome.,"Yes, a mutation has been identified in the gene encoding the transcription factor GFI1B as being associated with gray platelet syndrome. Specifically, a nonsense mutation was detected in this gene. This information is provided in the context.","Context: The gray platelet syndrome is a rare inherited bleeding disorder characterized  by macrothrombocytopenia and deficiency of alpha (α)-granules in platelets. The  genetic defect responsible for gray platelet syndrome was recently identified in, Context: The gray platelet syndrome is a hereditary, usually autosomal recessive bleeding  disorder caused by a deficiency of alpha granules in platelets. We detected a  nonsense mutation in the gene encoding the transcription factor GFI1B (growth, Context: The gray platelet syndrome is a hereditary, usually autosomal recessive bleeding  disorder caused by a deficiency of alpha granules in platelets. We detected a  nonsense mutation in the gene encoding the transcription factor GFI1B (growth, Context: The gray platelet syndrome is a hereditary, usually autosomal recessive bleeding  disorder caused by a deficiency of alpha granules in platelets. We detected a  nonsense mutation in the gene encoding the transcription factor GFI1B (growth, Context: The gray platelet syndrome is a hereditary, usually autosomal recessive bleeding  disorder caused by a deficiency of alpha granules in platelets. We detected a  nonsense mutation in the gene encoding the transcription factor GFI1B (growth, Context: The gray platelet syndrome is a hereditary, usually autosomal recessive bleeding  disorder caused by a deficiency of alpha granules in platelets. We detected a  nonsense mutation in the gene encoding the transcription factor GFI1B (growth","23100277, 24325358, 24325358, 24325358, 24325358, 24325358",GFI1B and NBEAL2 mutations are implicated in the Gray Platelet Syndrome.,"23861251, 21765412, 25258341, 21765413, 24325358, 23100277"
What are reactive metabolites?,"Yes, reactive metabolites are metabolites that can form idiosyncratically and bind covalently to cellular proteins, leading to adverse effects. They are usually detected with in vitro screening methods and their formation is","Context: idiosyncratic reactions form reactive metabolites to some degree. Covalent  binding of reactive metabolites to cellular proteins has also been shown in many  cases. However, studies to reveal the role of reactive metabolites and their, Context: metabolites. Strategies for dealing with reactive metabolites are reviewed. In  conclusion, we discuss the challenges and future needs in this field of  research., Context: acylpropionic acids, and alkynes have a much greater associated risk towards  formation of reactive metabolites than compounds that do not contain such  ""structural alerts"". Detection of reactive metabolites is usually done with in, Context: the detection of reactive metabolites and in understanding the structure  activity relationship. It is now widely accepted that compounds with certain  functional groups such as anilines, quinones, hydrazines, thiophenes, furans,, Context: to screen trapped reactive metabolites. The bioactivation of pulegone,  acetaminophen, and clozapine were reexamined by using this metabolomic approach.  In all these cases, a large number of trapped reactive metabolites were readily, Context: to screen trapped reactive metabolites. The bioactivation of pulegone,  acetaminophen, and clozapine were reexamined by using this metabolomic approach.  In all these cases, a large number of trapped reactive metabolites were readily","12093356, 16967439, 25174933, 25174933, 21469730, 21469730","Reactive metabolites are generated when a small molecule, commonly a drug or hydrocarbon, is broken down in the body. Reactive metabolites can cause cancer and other diseases as well as hepatoxicty. ","9144833, 21504003, 27031942, 21769097, 16967439, 22681489, 18788755, 25174933, 159767, 21469730, 26005795, 20391594, 25851819, 23090860, 12093356, 26627130, 26735163, 25363902, 25312212, 21148252, 17145699, 21083235, 16235238, 8987247, 9614200, 1628536"
Can acupuncture cause spinal epidural hematoma?,"Yes, acupuncture can cause spinal epidural hematoma. This is supported by the context which describes a case of cervical epidural hematoma after dry needling (a form of acupuncture) and another","Context: unusual and only a few cases of epidural hematoma after acupuncture have been  reported in the literature. We are presenting the first report of acute cervical  epidural hematoma after dry needling., Context: while two patients presented with post-procedural neurological deficits.  Surgical evacuation of the hematoma was performed in two patients while in  remaining two patients, surgery was initially recommended but not performed, Context: Unintentional acupuncture needling of the thoracic spinal canal produced a  spinal epidural hematoma and subarachnoid hemorrhage. This case demonstrates  that patients are sometimes reluctant to disclose folk medical treatments to, Context: Unintentional acupuncture needling of the thoracic spinal canal produced a  spinal epidural hematoma and subarachnoid hemorrhage. This case demonstrates  that patients are sometimes reluctant to disclose folk medical treatments to, Context: Spinal epidural hematoma is a rare complication associated with pain control  procedures such as facet block, acupuncture, epidural injection, etc. Although  it is an uncommon cause of acute myelopathy, and it may require surgical, Context: Spinal epidural hematoma is a rare complication associated with pain control  procedures such as facet block, acupuncture, epidural injection, etc. Although  it is an uncommon cause of acute myelopathy, and it may require surgical","21289580, 21082060, 8456713, 8456713, 21082060, 21082060","Yes, acupuncture can cause spinal epidural hematoma.","8456713, 21082060, 21289580, 27651774, 24094991, 25459742"
List features of the Triple A syndrome.,"Yes, the Triple A syndrome is characterized by achalasia, alacrima, and adrenal insufficiency. Additionally, patients often have neurological impairment and dermatological abnormalities. The context","Context: initial treatment with botulinum toxin (n = 20) was ultimately followed by  myotomy in 17 (85%). Ten out of 35 patients who underwent myotomy required a  repeat myotomy (29%). Patients with triple A syndrome developed symptoms, Context: molecular genetic data which demonstrated the marked phenotypic variability in  three unrelated patients with triple A syndrome. The final diagnosis of triple A  syndrome was confirmed by molecular analysis. In one patient with isolated, Context: The triple A or Allgrove syndrome is an autosomal-recessive disease (MIM*231550)  characterized by the triad of achalasia, alacrima and adrenocorticotropic  hormone (ACTH)-resistant adrenal insufficiency. Associated features of the, Context: multidisciplinary approach. What is known: • Triple A syndrome is characterised  by achalasia, alacrima, adrenal insufficiency, neurological impairment, and  dermatological abnormalities. • A precise genotype-phenotype correlation has, Context: achalasia was diagnosed, and in the presence of alacrima, the patient satisfies  the diagnostic criteria of triple A syndrome. In addition, a large number of  associated neurological and dermatological features were present in this, Context: patient. Moreover, he has dysmorphic facial features, which have not been  previously described in triple A syndrome. Triple A syndrome was confirmed by  molecular analysis, revealing a nonsense mutation p.W84X in the AAAS gene. The","27411173, 12752575, 12752575, 29255950, 18551317, 18551317","Triple A (Allgrove) syndrome is a rare autosomal recessive disorder characterized by cardinal features of adrenal insufficiency, achalasia, and alacrimia. It is frequently associated with neurological manifestations like polyneuropathy.","22000320, 12530689, 11196451, 30069287, 29255950, 27895694, 23691407, 29874194, 11815731, 18551317, 21656342, 16970037, 26354489, 15666842, 12429595, 12752575"
"In clinical trials, the H3 R antagonist CEP-26401 has a positive effect on cognition, yes or no?","Yes, according to the context, CEP-264","Context: in clinical trials., Context: The number of global clinical trials including Japan is increasing but still  much lower than those including the USA and Europe. The regulatory requirements  for clinical trials have been harmonized among Japan, USA, and Europe, and the, Context: CEP-26401 is a novel orally active, brain-penetrant, high-affinity histamine H3  receptor (H3R) antagonist, with potential therapeutic utility in cognition  enhancement. Two randomized, double-blind, placebo-controlled dose escalation, Context: CEP-26401 is a novel orally active, brain-penetrant, high-affinity histamine H3  receptor (H3R) antagonist, with potential therapeutic utility in cognition  enhancement. Two randomized, double-blind, placebo-controlled dose escalation, Context: CEP-26401 is a novel orally active, brain-penetrant, high-affinity histamine H3  receptor (H3R) antagonist, with potential therapeutic utility in cognition  enhancement. Two randomized, double-blind, placebo-controlled dose escalation, Context: CEP-26401 is a novel orally active, brain-penetrant, high-affinity histamine H3  receptor (H3R) antagonist, with potential therapeutic utility in cognition  enhancement. Two randomized, double-blind, placebo-controlled dose escalation","24309100, 30710642, 27222271, 27222271, 27222271, 27222271",The H3 R antagonist CEP-26401 had an effect on cognition.,"18469850, 22001260, 27222271"
Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?,"Yes, the context provides information about the organs mostly affected by SLE. The text mentions that brain, kidney, hematologic system, and mucocutaneous are among the frequently impacted areas in SLE patients.","Context: Systemic lupus erythematosus (SLE) is an autoimmune systemic disease with  multiple organ involvement with high morbidity and mortality rate. Among the  severe potential fatal complications are those of the central and peripheral, Context: BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease  with wide clinical features ranging from cutaneous manifestations to systemic  disease. Skin is one of the most commonly affected organs in SLE., Context: In systemic lupus erythematosus (SLE), brain and kidney are the most frequently  affected organs. Measurements of cerebral blood flow and metabolism by means of  positron emission tomography (PET) and single-photon emission tomography (SPET), Context: enzymes. The median SLE Disease Activity Index was 8.0 (range 0-20.0) at the  time of AAC. Other affected organs in SLE-AAC included kidney (11, 84.6%) and  hematologic system (11, 84.6%), followed by mucocutaneous (seven, 53.8%),, Context: enzymes. The median SLE Disease Activity Index was 8.0 (range 0-20.0) at the  time of AAC. Other affected organs in SLE-AAC included kidney (11, 84.6%) and  hematologic system (11, 84.6%), followed by mucocutaneous (seven, 53.8%),, Context: Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect  almost any organ in the human body. Despite significant advancements in our  understanding of SLE over the recent years, its exact mode of onset and disease","26366317, 25186992, 7588946, 28355987, 28355987, 29169635","In systemic lupus erythematosus (SLE), brain and kidney are the most frequently affected organs. The heart is one of the most frequently affected organs in SLE. Skin is one of the most commonly affected organs in SLE. Other affected organs in SLE-AAC included hematologic system (11, 84.6%), followed by mucocutaneous (seven, 53.8%), musculoskeletal (seven, 53.8%) and neuropsychiatric (two, 15.4%) systems.","24268009, 25186992, 7588946, 28355987, 19758166, 21767292"
